{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:46:12Z","timestamp":1793969172648,"version":"4.8.0"},"reference-count":554,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009104","name":"Department of Health Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009104","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100021508","name":"Department of Human Resources","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021508","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.arr.2024.102538","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T20:23:42Z","timestamp":1728505422000},"page":"102538","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Small molecule modulators of alpha-synuclein aggregation and toxicity: Pioneering an emerging arsenal against Parkinson\u2019s disease"],"prefix":"10.1016","volume":"101","author":[{"given":"Ishfaq Ahmad","family":"Ahanger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanveer Ali","family":"Dar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2024.102538_bib1","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/mds.25729","article-title":"Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson's disease","volume":"29","author":"Abbott","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2024.102538_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood\u2013brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2024.102538_bib3","doi-asserted-by":"crossref","first-page":"7765","DOI":"10.1016\/S0021-9258(18)36013-7","article-title":"Nucleation-controlled aggregation of deoxyhemoglobin S","volume":"254","author":"Adachi","year":"1979","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102538_bib4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s12017-008-8053-y","article-title":"Creatine and its potential therapeutic value for targeting cellular energy impairment in neurodegenerative diseases","volume":"10","author":"Adhihetty","year":"2008","journal-title":"Neuromol. Med."},{"key":"10.1016\/j.arr.2024.102538_bib5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.neuroscience.2016.02.038","article-title":"Creatine salts provide neuroprotection even after partial impairment of the creatine transporter","volume":"340","author":"Adriano","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.arr.2024.102538_bib6","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/j.bpj.2017.08.027","article-title":"Modification of C terminus provides new insights into the mechanism of \u03b1-synuclein aggregation","volume":"113","author":"Afitska","year":"2017","journal-title":"Biophys. J."},{"key":"10.1016\/j.arr.2024.102538_bib7","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.bbapap.2019.05.003","article-title":"\u03b1-Synuclein aggregation at low concentrations","volume":"1867","author":"Afitska","year":"2019","journal-title":"Biochim. Et. Biophys. Acta -Proteins Proteom."},{"key":"10.1016\/j.arr.2024.102538_bib8","first-page":"251p","article-title":"Delineating aggregation behavior of bovine serum albumin: A biophysical approach to modulate protein aggregation through cosolutes","author":"Ahanger","year":"2021","journal-title":"Shodhganga@INFLIBNET Centre"},{"key":"10.1016\/j.arr.2024.102538_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.636454","article-title":"Rationalizing the role of monosodium glutamate in the protein aggregation through biophysical approaches: Potential impact on neurodegeneration","volume":"15","author":"Ahanger","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib10","series-title":"Cellular Osmolytes: From Chaperoning Protein Folding to Clinical Perspectives","first-page":"161","article-title":"Diverse biological functions of myo-inositol: a neuro-metabolite, osmoprotectant, and diagnostic marker","author":"Ahanger","year":"2024"},{"key":"10.1016\/j.arr.2024.102538_bib11","article-title":"Comprehensive perspective towards the management of proteinopathies by elucidating protein misfolding and aggregation","author":"Ahanger","year":"2023","journal-title":"CNS Neurol. Disord. -Drug Targets"},{"key":"10.1016\/j.arr.2024.102538_bib12","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1021\/acsomega.0c05638","article-title":"Heparin accelerates the protein aggregation via the downhill polymerization mechanism: multi-spectroscopic studies to delineate the implications on proteinopathies","volume":"6","author":"Ahanger","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.arr.2024.102538_bib13","article-title":"Counteraction of the cetyltrimethylammonium bromide-induced protein aggregation by Heparin: potential impact on protein aggregation and neurodegenerative diseases using biophysical approaches","author":"Ahanger","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.arr.2024.102538_bib14","series-title":"Autism Spectrum Disorder and Alzheimer's Disease: Advances in Research","first-page":"43","article-title":"The pathogenesis and complications associated with autism spectrum disorder and Alzheimer\u2019s disease: a comparative study","author":"Ahanger","year":"2022"},{"key":"10.1016\/j.arr.2024.102538_bib15","doi-asserted-by":"crossref","first-page":"9193","DOI":"10.1074\/jbc.M111.325548","article-title":"Curcumin prevents aggregation in \u03b1-synuclein by increasing reconfiguration rate","volume":"287","author":"Ahmad","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102538_bib16","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.4103\/1673-5374.160106","article-title":"The role of quercetin on the survival of neuron-like PC12 cells and the expression of \u03b1-synuclein","volume":"10","author":"Ahn","year":"2015","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.arr.2024.102538_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep09862","article-title":"Curcumin Pyrazole and its derivative (N-(3-Nitrophenylpyrazole) Curcumin inhibit aggregation, disrupt fibrils and modulate toxicity of Wild type and Mutant \u03b1-Synuclein","volume":"5","author":"Ahsan","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2024.102538_bib18","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/jnc.14808","article-title":"\u03b1-synuclein oligomers and fibrils: a spectrum of species, a spectrum of toxicities","volume":"150","author":"Alam","year":"2019","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2024.102538_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102944","article-title":"Anti-\u03b1-synuclein ASO delivered to monoamine neurons prevents \u03b1-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeys","volume":"59","author":"Alarc\u00f3n-Ar\u00eds","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.arr.2024.102538_bib20","doi-asserted-by":"crossref","first-page":"7280","DOI":"10.1073\/pnas.1200425109","article-title":"Tandem mass spectrometry identifies many mouse brain O-GlcNAcylated proteins including EGF domain-specific O-GlcNAc transferase targets","volume":"109","author":"Alfaro","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2024.102538_bib21","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1016\/j.ijbiomac.2022.10.066","article-title":"Zinc ions prevent \u03b1-synuclein aggregation by enhancing chaperone function of human serum albumin","volume":"222","author":"Al-Harthi","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.arr.2024.102538_bib22","doi-asserted-by":"crossref","first-page":"12690","DOI":"10.1021\/acsomega.1c06990","article-title":"Brain metabolite, myo-inositol, inhibits catalase activity: a mechanism of the distortion of the antioxidant defense system in Alzheimer\u2019s disease","volume":"7","author":"Ali","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.arr.2024.102538_bib23","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijbiomac.2022.04.013","article-title":"Effect of polyol osmolytes on the structure-function integrity and aggregation propensity of catalase: A comprehensive study based on spectroscopic and molecular dynamic simulation measurements","volume":"209","author":"Ali","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.arr.2024.102538_bib24","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/0026-0495(93)90198-W","article-title":"Serum betaine, N, N-dimethylglycine and N-methylglycine levels in patients with cobalamin and folate deficiency and related inborn errors of metabolism","volume":"42","author":"Allen","year":"1993","journal-title":"Metabolism"},{"key":"10.1016\/j.arr.2024.102538_bib25","doi-asserted-by":"crossref","first-page":"29739","DOI":"10.1074\/jbc.M600933200","article-title":"Phosphorylation of Ser-129 is the dominant pathological modification of \u03b1-synuclein in familial and sporadic Lewy body disease","volume":"281","author":"Anderson","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102538_bib26","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1242\/jcs.180737","article-title":"Ca2+ is a key factor in \u03b1-synuclein-induced neurotoxicity","volume":"129","author":"Angelova","year":"2016","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.arr.2024.102538_bib27","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1074\/jbc.M208249200","article-title":"Cellular polyamines promote the aggregation of \u03b1-synuclein","volume":"278","author":"Antony","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102538_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-017-0452-6","article-title":"Mechanisms underlying extensive Ser129-phosphorylation in \u03b1-synuclein aggregates","volume":"5","author":"Arawaka","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.arr.2024.102538_bib29","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3389\/fnagi.2014.00197","article-title":"Structure activity relationship of phenolic acid inhibitors of \u03b1-synuclein fibril formation and toxicity","volume":"6","author":"Ardah","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib30","first-page":"S123","article-title":"CDP-choline as a biological supplement during neurorecovery: a focused review","volume":"3","author":"Arenth","year":"2011","journal-title":"PMR"},{"key":"10.1016\/j.arr.2024.102538_bib31","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrd1343","article-title":"Small-molecule inhibitors of protein\u2013protein interactions: progressing towards the dream","volume":"3","author":"Arkin","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.arr.2024.102538_bib32","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2174\/1871527317666180816095707","article-title":"Effects of exercise and ferulic acid on alpha synuclein and neuroprotective heat shock protein 70 in an experimental model of Parkinsonism disease","volume":"18","author":"Askar","year":"2019","journal-title":"CNS Neurol. Disord. -Drug Targets"},{"key":"10.1016\/j.arr.2024.102538_bib33","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.cca.2018.02.022","article-title":"Serum metabolomics study in a group of Parkinson's disease patients from northern India","volume":"480","author":"Babu","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.arr.2024.102538_bib34","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1089\/ars.2011.4429","article-title":"Lipid peroxidation product 4-hydroxy-2-nonenal promotes seeding-capable oligomer formation and cell-to-cell transfer of \u03b1-synuclein","volume":"18","author":"Bae","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.arr.2024.102538_bib35","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0165-0173(97)00045-3","article-title":"Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death","volume":"25","author":"Bains","year":"1997","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.arr.2024.102538_bib36","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11302-022-09869-z","article-title":"Gallic acid modulates purine metabolism and oxidative stress induced by ethanol exposure in zebrafish brain","volume":"18","author":"Baldin","year":"2022","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.arr.2024.102538_bib37","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/j.bpj.2010.06.035","article-title":"The N-terminus of the intrinsically disordered protein \u03b1-synuclein triggers membrane binding and helix folding","volume":"99","author":"Bartels","year":"2010","journal-title":"Biophys. J."},{"key":"10.1016\/j.arr.2024.102538_bib38","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature10324","article-title":"\u03b1-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation","volume":"477","author":"Bartels","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.arr.2024.102538_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103727","article-title":"N-alpha-acetylation of \u03b1-synuclein increases its helical folding propensity, GM1 binding specificity and resistance to aggregation","volume":"9","author":"Bartels","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.arr.2024.102538_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102017","article-title":"A comprehensive review of protein misfolding disorders, underlying mechanism, clinical diagnosis, and therapeutic strategies","author":"Basha","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2024.102538_bib41","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3390\/biom11030414","article-title":"Trehalose restrains the fibril load towards \u03b1-lactalbumin aggregation and halts fibrillation in a concentration-dependent manner","volume":"11","author":"Bashir","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.arr.2024.102538_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e27949","article-title":"Probing protein aggregation through spectroscopic insights and multimodal approaches: a comprehensive review for counteracting neurodegenerative disorders","author":"Bashir","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.arr.2024.102538_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102276","article-title":"Amyloid-induced neurodegeneration: a comprehensive review through aggregomics perception of proteins in health and pathology","author":"Bashir","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2024.102538_bib44","doi-asserted-by":"crossref","first-page":"203","DOI":"10.5958\/0974-360X.2018.00038.0","article-title":"Favorable binding of quercetin to \u03b1-synuclein as potential target in Parkinson disease: an insilico approach","volume":"11","author":"Baul","year":"2018","journal-title":"Res. J. Pharm. Technol."},{"key":"10.1016\/j.arr.2024.102538_bib45","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1039\/D2CC00212D","article-title":"Rationally designed helical peptidomimetics disrupt \u03b1-synuclein fibrillation","volume":"58","author":"Bavinton","year":"2022","journal-title":"Chem. Commun."},{"key":"10.1016\/j.arr.2024.102538_bib46","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s00726-011-0851-0","article-title":"Neuroprotective effects of creatine","volume":"40","author":"Beal","year":"2011","journal-title":"Amino Acids"},{"key":"10.1016\/j.arr.2024.102538_bib47","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13024-023-00613-8","article-title":"Cerebrospinal fluid lipoproteins inhibit \u03b1-synuclein aggregation by interacting with oligomeric species in seed amplification assays","volume":"18","author":"Bellomo","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2024.102538_bib48","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.neuron.2013.09.004","article-title":"The function of \u03b1-synuclein","volume":"79","author":"Bendor","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2024.102538_bib49","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.jasms.2004.08.003","article-title":"\u03b1-Synuclein: Stable compact and extended monomeric structures and pH dependence of dimer formation","volume":"15","author":"Bernstein","year":"2004","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.arr.2024.102538_bib50","doi-asserted-by":"crossref","first-page":"476","DOI":"10.2174\/1871527322666230331121028","article-title":"Rationale and development of tavapadon, a D1\/D5-selective partial dopamine agonist for the treatment of Parkinson\u2019s disease","volume":"23","author":"Bezard","year":"2024","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.arr.2024.102538_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-32655-0","article-title":"Morphological evaluation of meta-stable oligomers of \u03b1-synuclein with small-angle neutron scattering","volume":"8","author":"Bhak","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2024.102538_bib52","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.ijbiomac.2021.04.060","article-title":"Trimethylamine N-oxide alters structure-function integrity of \u03b2-casein: Structural disorder co-regulates the aggregation propensity and chaperone activity","volume":"182","author":"Bhat","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.arr.2024.102538_bib53","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1080\/07391102.2022.2053744","article-title":"Urea ameliorates trimethylamine N-oxide-Induced aggregation of intrinsically disordered \u03b1-casein protein: the other side of the urea-methylamine counteraction","volume":"41","author":"Bhat","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.arr.2024.102538_bib54","doi-asserted-by":"crossref","first-page":"6572","DOI":"10.1038\/s41598-017-06836-2","article-title":"Trimethylamine N-oxide abolishes the chaperone activity of \u03b1-casein: an intrinsically disordered protein","volume":"7","author":"Bhat","year":"2017","journal-title":"Sci. rep."},{"key":"10.1016\/j.arr.2024.102538_bib55","first-page":"121","article-title":"Modulation of protein aggregation\/fibrillation by osmolytes. Cellular Osmolytes: From Chaperoning Protein Folding to","author":"Bhat","year":"2017","journal-title":"Clin. Perspect."},{"key":"10.1016\/j.arr.2024.102538_bib56","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1038\/s41598-020-60430-7","article-title":"Taurine induces an ordered but functionally inactive conformation in intrinsically disordered casein proteins","volume":"10","author":"Bhat","year":"2020","journal-title":"Sci. rep."},{"key":"10.1016\/j.arr.2024.102538_bib57","doi-asserted-by":"crossref","DOI":"10.1111\/bcpt.13839","article-title":"Betaine\u2014the dark knight of the brain.","author":"Bhatt","year":"2023","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.arr.2024.102538_bib58","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1172\/JCI35781","article-title":"Hsp104 antagonizes \u03b1-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease","volume":"118","author":"Bianco","year":"2008","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.arr.2024.102538_bib59","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nchembio.719","article-title":"Small-molecule conversion of toxic oligomers to nontoxic \u03b2-sheet\u2013rich amyloid fibrils","volume":"8","author":"Bieschke","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.arr.2024.102538_bib60","doi-asserted-by":"crossref","first-page":"7710","DOI":"10.1073\/pnas.0910723107","article-title":"EGCG remodels mature \u03b1-synuclein and amyloid-\u03b2 fibrils and reduces cellular toxicity","volume":"107","author":"Bieschke","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2024.102538_bib61","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3389\/fnins.2016.00269","article-title":"Parkinson's disease and neurodegeneration: GABA-collapse hypothesis","volume":"10","author":"B\u0142aszczyk","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib62","first-page":"17","article-title":"Protein stabilization by naturally occurring osmolytes","author":"Bolen","year":"2001","journal-title":"Protein Struct., Stab., Fold."},{"key":"10.1016\/j.arr.2024.102538_bib63","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1146\/annurev.biochem.77.061306.131357","article-title":"Structure and energetics of the hydrogen-bonded backbone in protein folding","volume":"77","author":"Bolen","year":"2008","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.arr.2024.102538_bib64","doi-asserted-by":"crossref","first-page":"15208","DOI":"10.1021\/bi001071d","article-title":"Effects of guanidine hydrochloride on the proton inventory of proteins: implications on interpretations of protein stability","volume":"39","author":"Bolen","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.arr.2024.102538_bib65","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2024.102538_bib66","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jmb.2010.10.027","article-title":"The anti-Parkinsonian drug selegiline delays the nucleation phase of \u03b1-synuclein aggregation leading to the formation of nontoxic species","volume":"405","author":"Braga","year":"2011","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.arr.2024.102538_bib67","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bbadis.2011.10.002","article-title":"\u03b1-Synuclein misfolding and Parkinson's disease","volume":"1822","author":"Breydo","year":"2012","journal-title":"Biochim. Et. Biophys. Acta -Mol. Basis Dis."},{"key":"10.1016\/j.arr.2024.102538_bib68","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bbadis.2011.10.002","article-title":"\u03b1-Synuclein misfolding and Parkinson's disease","volume":"1822","author":"Breydo","year":"2012","journal-title":"Biochim. Et. Biophys. Acta (BBA)-Mol. Basis Dis."},{"key":"10.1016\/j.arr.2024.102538_bib69","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S1474-4422(03)00593-3","article-title":"Alzheimer's disease: the glycosaminoglycan sink","volume":"2","author":"Briani","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2024.102538_bib70","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fnins.2018.00080","article-title":"Mechanisms of \u03b1-synuclein induced synaptopathy in Parkinson's disease","volume":"12","author":"Bridi","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib71","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/jnnp.68.6.685","article-title":"Dopamine agonists: their role in the treatment of Parkinson's disease","volume":"68","author":"Brooks","year":"2000","journal-title":"J. Neurol., Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2024.102538_bib72","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.1021\/ja5131726","article-title":"Elucidating the role of site-specific nitration of \u03b1-synuclein in the pathogenesis of Parkinson\u2019s disease via protein semisynthesis and mutagenesis","volume":"137","author":"Burai","year":"2015","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.arr.2024.102538_bib73","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1126\/science.1195227","article-title":"\u03b1-Synuclein promotes SNARE-complex assembly in vivo and in vitro","volume":"329","author":"Burr\u00e9","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.arr.2024.102538_bib74","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1093\/brain\/awad150","article-title":"Advances in understanding the function of alpha-synuclein: Implications for Parkinson\u2019s disease","volume":"146","author":"Calabresi","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.arr.2024.102538_bib75","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.7326\/M22-1438","article-title":"Oral ENT-01 targets enteric neurons to treat constipation in Parkinson disease: a randomized controlled trial","volume":"175","author":"Camilleri","year":"2022","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.arr.2024.102538_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtn.2022.05.037","article-title":"Suppression of abnormal \u03b1-synuclein expression by activation of BDNF transcription ameliorates Parkinson\u2019s disease-like pathology","volume":"29","author":"Cao","year":"2022","journal-title":"Mol. Ther. -Nucleic Acids"},{"key":"10.1016\/j.arr.2024.102538_bib77","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1096\/fj.04-3437fje","article-title":"Dopamine promotes \u03b1-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway","volume":"19","author":"Cappai","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.arr.2024.102538_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2022.135752","article-title":"Aluminium exposure leads to neurodegeneration and alters the expression of marker genes involved to parkinsonism in zebrafish brain","volume":"307","author":"Capriello","year":"2022","journal-title":"Chemosphere"},{"key":"10.1016\/j.arr.2024.102538_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110675","article-title":"Synaptic vesicle binding of \u03b1-synuclein is modulated by \u03b2-and \u03b3-synucleins","volume":"39","author":"Carnazza","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.arr.2024.102538_bib80","doi-asserted-by":"crossref","first-page":"9579","DOI":"10.1038\/s41598-021-88910-4","article-title":"Nicotine suppresses Parkinson\u2019s disease like phenotypes induced by Synphilin-1 overexpression in Drosophila melanogaster by increasing tyrosine hydroxylase and dopamine levels","volume":"11","author":"Carvajal-Oliveros","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2024.102538_bib81","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1038\/s41467-021-21937-3","article-title":"The release of toxic oligomers from \u03b1-synuclein fibrils induces dysfunction in neuronal cells","volume":"12","author":"Cascella","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2024.102538_bib82","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1046\/j.1471-4159.1997.69062452.x","article-title":"Perlecan binds to the \u03b2-amyloid proteins (A\u03b2) of Alzheimer's disease, accelerates A\u03b2 fibril formation, and maintains A\u03b2 fibril stability","volume":"69","author":"Castillo","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2024.102538_bib83","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s11064-012-0780-7","article-title":"Differential activation of the ER stress factor XBP1 by oligomeric assemblies","volume":"37","author":"Castillo-Carranza","year":"2012","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.arr.2024.102538_bib84","doi-asserted-by":"crossref","first-page":"7416","DOI":"10.1016\/j.bmc.2011.10.049","article-title":"Molecular insights into human monoamine oxidase (MAO) inhibition by 1, 4-naphthoquinone: Evidences for menadione (vitamin K3) acting as a competitive and reversible inhibitor of MAO","volume":"19","author":"Cerqueira","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.arr.2024.102538_bib85","article-title":"Role of alpha-synuclein in the regulation of dopamine neurotransmission in the striatum","author":"Chadchankar","year":"2013","journal-title":"It\u00e4-Suom. Yliop."},{"key":"10.1016\/j.arr.2024.102538_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2023.105501","article-title":"Corn gluten meal peptides inhibit prolyl oligopeptidase and modulate \u03b1-synuclein aggregation in KCl-treated SH-SY5Y cells","volume":"104","author":"Chanajon","year":"2023","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.arr.2024.102538_bib87","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","article-title":"\u03b1-synuclein locus duplication as a cause of familial Parkinson's disease","volume":"364","author":"Chartier-Harlin","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2024.102538_bib88","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s12551-017-0353-8","article-title":"Recent progress on understanding the mechanisms of amyloid nucleation","volume":"10","author":"Chatani","year":"2018","journal-title":"Biophys. Rev."},{"key":"10.1016\/j.arr.2024.102538_bib89","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41419-018-0468-2","article-title":"Taurine protects dopaminergic neurons in a mouse Parkinson\u2019s disease model through inhibition of microglial M1 polarization","volume":"9","author":"Che","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.arr.2024.102538_bib90","first-page":"E1994","article-title":"Structural characterization of toxic oligomers that are kinetically trapped during \u03b1-synuclein fibril formation","volume":"112","author":"Chen","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2024.102538_bib91","article-title":"Amide derivatives of Gallic acid: Design, synthesis and evaluation of inhibitory activities against in vitro \u03b1-synuclein aggregation. Bioorganic","volume":"28","author":"Chen","year":"2020","journal-title":"Med. Chem."},{"key":"10.1016\/j.arr.2024.102538_bib92","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.3390\/cells9051230","article-title":"Lactulose and melibiose inhibit \u03b1-synuclein aggregation and up-regulate autophagy to reduce neuronal vulnerability","volume":"9","author":"Chen","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.arr.2024.102538_bib93","article-title":"HtrA1 prevents and reverses \u03b1-synuclein aggregation, rendering it non-toxic and seeding incompetent","author":"Chen","year":"2023","journal-title":"Res. Sq."},{"key":"10.1016\/j.arr.2024.102538_bib94","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/s41593-022-01140-3","article-title":"Pathological structural conversion of \u03b1-synuclein at the mitochondria induces neuronal toxicity","volume":"25","author":"Choi","year":"2022","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib95","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1073\/pnas.1218424110","article-title":"Large \u03b1-synuclein oligomers inhibit neuronal SNARE-mediated vesicle docking","volume":"110","author":"Choi","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2024.102538_bib96","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/mrm.22857","article-title":"Measurement of glycine in the human brain in vivo by 1H-MRS at 3 T: application in brain tumors","volume":"66","author":"Choi","year":"2011","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.arr.2024.102538_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11910-015-0549-x","article-title":"The prion hypothesis of Parkinson\u2019s disease","volume":"15","author":"Chu","year":"2015","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.arr.2024.102538_bib98","article-title":"UB-312 Displays Target Engagement of Toxic Alpha-Synuclein in Phase 1 Trial for Parkinson Disease","volume":"NA-NA","author":"Ciccone","year":"2023","journal-title":"Neurol. Live"},{"key":"10.1016\/j.arr.2024.102538_bib99","article-title":"UB-312 Reduces \u03b1-Synuclein in Parkinson Disease in Phase 1 Trial","volume":"NA-NA","author":"Ciccone","year":"2024","journal-title":"Neurol. Live"},{"key":"10.1016\/j.arr.2024.102538_bib100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012333","article-title":"Oral N-acetyl-cysteine attenuates loss of dopaminergic terminals in \u03b1-synuclein overexpressing mice","volume":"5","author":"Clark","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2024.102538_bib101","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jmb.2012.02.031","article-title":"From macroscopic measurements to microscopic mechanisms of protein aggregation","volume":"421","author":"Cohen","year":"2012","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.arr.2024.102538_bib102","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1021\/bi011711s","article-title":"Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from \u03b1-synuclein in vitro","volume":"41","author":"Cohlberg","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.arr.2024.102538_bib103","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.135633","article-title":"\u03b1-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson\u2019s disease","volume":"6","author":"Cole","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.arr.2024.102538_bib104","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.nbd.2017.07.007","article-title":"Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric form","volume":"106","author":"Collier","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2024.102538_bib105","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1073\/pnas.97.2.571","article-title":"Acceleration of oligomerization, not fibrillization, is a shared property of both \u03b1-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy","volume":"97","author":"Conway","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2024.102538_bib106","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1126\/science.1063522","article-title":"Kinetic stabilization of the \u03b1-synuclein protofibril by a dopamine-\u03b1-synuclein adduct","volume":"294","author":"Conway","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.arr.2024.102538_bib107","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0301-4622(01)00222-8","article-title":"Heat does not come in different colours: entropy\u2013enthalpy compensation, free energy windows, quantum confinement, pressure perturbation calorimetry, solvation and the multiple causes of heat capacity effects in biomolecular interactions","volume":"93","author":"Cooper","year":"2001","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.arr.2024.102538_bib108","first-page":"368","article-title":"Pimavanserin (Nuplazid): a treatment for hallucinations and delusions associated with Parkinson\u2019s disease","volume":"42","author":"Cruz","year":"2017","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.arr.2024.102538_bib109","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1126\/science.1101738","article-title":"Impaired degradation of mutant \u03b1-synuclein by chaperone-mediated autophagy","volume":"305","author":"Cuervo","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.arr.2024.102538_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115965","article-title":"Brazilin-7-acetate, a novel potential drug of Parkinson's disease, hinders the formation of \u03b1-synuclein fibril, mitigates cytotoxicity, and decreases oxidative stress","volume":"264","author":"Cui","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.arr.2024.102538_bib111","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000511035","article-title":"The Protective Effect of Tetrahydroxystilbene Glucoside on High Glucose-Induced Injury in Human Umbilical Vein Endothelial Cells through the PI3K\/Akt\/eNOS Pathway and Regulation of Bcl-2\/Bax","volume":"58","author":"Cui","year":"2021","journal-title":"J. Vasc. Res."},{"key":"10.1016\/j.arr.2024.102538_bib112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-6606-2-5","article-title":"Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo","volume":"2","author":"Cullen","year":"2009","journal-title":"Mol. Brain"},{"key":"10.1016\/j.arr.2024.102538_bib113","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.neuint.2012.10.001","article-title":"Vitamins K interact with N-terminus \u03b1-synuclein and modulate the protein fibrillization in vitro. Exploring the interaction between quinones and \u03b1-synuclein","volume":"62","author":"da Silva","year":"2013","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.arr.2024.102538_bib114","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.3390\/ijms25021135","article-title":"The 75\u201399C-Terminal Peptide of URG7 Protein Promotes \u03b1-Synuclein Disaggregation","volume":"25","author":"Dandurand","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102538_bib115","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1038\/s41598-019-39480-z","article-title":"Cyclized NDGA modifies dynamic \u03b1-synuclein monomers preventing aggregation and toxicity","volume":"9","author":"Daniels","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2024.102538_bib116","doi-asserted-by":"crossref","first-page":"7823","DOI":"10.1021\/ac901176t","article-title":"Preferentially increased nitration of \u03b1-synuclein at tyrosine-39 in a cellular oxidative model of Parkinson\u2019s disease","volume":"81","author":"Danielson","year":"2009","journal-title":"Anal. Chem."},{"key":"10.1016\/j.arr.2024.102538_bib117","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1523\/JNEUROSCI.2617-07.2007","article-title":"Different species of \u03b1-synuclein oligomers induce calcium influx and seeding","volume":"27","author":"Danzer","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib118","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1096\/fj.10-164624","article-title":"Heat-shock protein 70 modulates toxic extracellular \u03b1-synuclein oligomers and rescues trans-synaptic toxicity","volume":"25","author":"Danzer","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.arr.2024.102538_bib119","doi-asserted-by":"crossref","DOI":"10.2174\/18715273113126660135","article-title":"Molecular Linkages Between Diabetes and Alzheimer\u2019s Disease Current Scenario and Future Prospects","volume":"13","author":"Dar","year":"2014","journal-title":"CNS & Neurological Disorders-Drug Targets"},{"key":"10.1016\/j.arr.2024.102538_bib120","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bpc.2007.01.006","article-title":"Guanidinium chloride and urea denaturations of \u03b2-lactoglobulin A at pH 2.0 and 25 C: the equilibrium intermediate contains non-native structures (helix, tryptophan and hydrophobic patches)","volume":"127","author":"Dar","year":"2007","journal-title":"Biophys. chemistry"},{"key":"10.1016\/j.arr.2024.102538_bib121","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1021\/acs.biochem.9b00215","article-title":"Tau interacts with the C-terminal region of \u03b1-synuclein, promoting formation of toxic aggregates with distinct molecular conformations","volume":"58","author":"Dasari","year":"2019","journal-title":"Biochemistry"},{"key":"10.1016\/j.arr.2024.102538_bib122","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1016\/j.jmb.2013.08.006","article-title":"Hsp90 inhibits \u03b1-synuclein aggregation by interacting with soluble oligomers","volume":"425","author":"Daturpalli","year":"2013","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.arr.2024.102538_bib123","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s42003-019-0598-9","article-title":"Alpha-synuclein stepwise aggregation reveals features of an early onset mutation in Parkinson\u2019s disease","volume":"2","author":"de Oliveira","year":"2019","journal-title":"Commun. Biol."},{"key":"10.1016\/j.arr.2024.102538_bib124","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1021\/accountsmr.1c00193","article-title":"Inhibiting protein aggregation by small molecule-based colloidal nanoparticles","volume":"3","author":"Debnath","year":"2021","journal-title":"Acc. Mater. Res."},{"key":"10.1016\/j.arr.2024.102538_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110491","article-title":"Roflumilast escalates \u03b1-synuclein aggregate degradation in rotenone-induced Parkinson's disease in rats: modulation of the ubiquitin-proteasome system and endoplasmic reticulum stress","volume":"379","author":"Desouky","year":"2023","journal-title":"Chem. -Biol. Interact."},{"key":"10.1016\/j.arr.2024.102538_bib126","doi-asserted-by":"crossref","first-page":"9089","DOI":"10.1074\/jbc.M710012200","article-title":"Mitochondrial import and accumulation of \u03b1-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain","volume":"283","author":"Devi","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102538_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.166953","article-title":"Prion-like C-terminal domain of TDP-43 and \u03b1-Synuclein interact synergistically to generate neurotoxic hybrid fibrils","volume":"433","author":"Dhakal","year":"2021","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.arr.2024.102538_bib128","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2741\/e835","article-title":"Myricetin attenuates neurodegeneration and cognitive impairment in Parkinsonism","volume":"10","author":"Dhanraj","year":"2018","journal-title":"Front. Biosci."},{"key":"10.1016\/j.arr.2024.102538_bib129","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.3390\/ijms21082858","article-title":"GM1 oligosaccharide crosses the human blood\u2013brain barrier in vitro by a paracellular route","volume":"21","author":"Di Biase","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102538_bib130","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0196-9781(02)00068-2","article-title":"Glycosaminoglycans and \u03b2-amyloid, prion and tau peptides in neurodegenerative diseases","volume":"23","author":"D\u0131\u0301az-Nido","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.arr.2024.102538_bib131","article-title":"3.3 Relevance of C-terminal residues for amyloid-\u03b2 binding to platelet integrin \u03b1IIb\u03b23 and amyloid-\u03b2 fibril formation","volume":"23","author":"Donner","year":"2017","journal-title":"Mitverfassung Des. Manuskr. %J. Einfluss Von. Thrombozyten auf die Progress. der Alzheimer Erkrank."},{"key":"10.1016\/j.arr.2024.102538_bib132","article-title":"Role of enteric glia and microbiota-gut-brain axis in parkinson disease pathogenesis","volume":"84","author":"Dos Santos","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2024.102538_bib133","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/cbic.201200059","article-title":"Hunting the Chameleon: structural conformations of the intrinsically disordered protein alpha-synuclein","volume":"13","author":"Drescher","year":"2012","journal-title":"ChemBioChem"},{"key":"10.1016\/j.arr.2024.102538_bib134","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nsmb.1437","article-title":"EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers","volume":"15","author":"Ehrnhoefer","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.arr.2024.102538_bib135","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd4593","article-title":"Targeting protein aggregation for the treatment of degenerative diseases","volume":"14","author":"Eisele","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.arr.2024.102538_bib136","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1006\/jmbi.2001.4538","article-title":"Conformational properties of \u03b1-synuclein in its free and lipid-associated states","volume":"307","author":"Eliezer","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.arr.2024.102538_bib137","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1074\/jbc.M010316200","article-title":"\u03b1-Synuclein is phosphorylated by members of the Src family of protein-tyrosine kinases","volume":"276","author":"Ellis","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102538_bib138","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/15216540410001674003","article-title":"The role of protein misfolding in the pathogenesis of human diseases","volume":"56","author":"Ellisdon","year":"2004","journal-title":"IUBMB life"},{"key":"10.1016\/j.arr.2024.102538_bib139","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.neurobiolaging.2008.07.008","article-title":"Cell-produced \u03b1-synuclein oligomers are targeted to, and impair, the 26S proteasome","volume":"31","author":"Emmanouilidou","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2024.102538_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101391","article-title":"Living with the enemy: From protein-misfolding pathologies we know, to those we want to know","volume":"70","author":"Emwas","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2024.102538_bib141","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1093\/hmg\/ddl242","article-title":"\u03b2-synuclein modulates \u03b1-synuclein neurotoxicity by reducing \u03b1-synuclein protein expression","volume":"15","author":"Fan","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.arr.2024.102538_bib142","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.molcel.2018.11.028","article-title":"Lipidomic analysis of \u03b1-synuclein neurotoxicity identifies stearoyl CoA desaturase as a target for Parkinson treatment","volume":"73","author":"Fanning","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.arr.2024.102538_bib143","doi-asserted-by":"crossref","first-page":"234","DOI":"10.2478\/s11658-010-0006-4","article-title":"Flavonoid transport across RBE4 cells: A blood-brain barrier model","volume":"15","author":"Faria","year":"2010","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"813","key":"10.1016\/j.arr.2024.102538_bib144","article-title":"Taurine Prevents the Neurotoxic Effects of Manganese on the Physiological Response of a Cilio-Inhibitory Dopaminergic System","author":"Fatoke-Osobukola","year":"2017","journal-title":"FASEB J. 31, 815. 813-815"},{"key":"10.1016\/j.arr.2024.102538_bib145","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.biochi.2014.11.011","article-title":"Anti-fibrillation potency of caffeic acid against an antidepressant induced fibrillogenesis of human \u03b1-synuclein: Implications for Parkinson's disease","volume":"108","author":"Fazili","year":"2015","journal-title":"Biochimie"},{"key":"10.1016\/j.arr.2024.102538_bib146","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/35006074","article-title":"A Drosophila model of Parkinson's disease","volume":"404","author":"Feany","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.arr.2024.102538_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102373","article-title":"Mechanism and therapeutic targets of the involvement of a novel lysosomal proton channel TMEM175 in Parkinson's disease","volume":"100","author":"Feng","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2024.102538_bib148","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00109-007-0156-7","article-title":"Properties of scyllo\u2013inositol as a therapeutic treatment of AD-like pathology","volume":"85","author":"Fenili","year":"2007","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.arr.2024.102538_bib149","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3390\/biomedicines9050491","article-title":"Alteration in the cerebrospinal fluid lipidome in Parkinson\u2019s disease: a post-mortem pilot study","volume":"9","author":"Fern\u00e1ndez-Irigoyen","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.arr.2024.102538_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106375","article-title":"Rabphilin-3A as a novel target to reverse \u03b1-synuclein-induced synaptic loss in Parkinson\u2019s disease","volume":"183","author":"Ferrari","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.arr.2024.102538_bib151","doi-asserted-by":"crossref","first-page":"17826","DOI":"10.1073\/pnas.1201802109","article-title":"Counteracting chemical chaperone effects on the single-molecule \u03b1-synuclein structural landscape","volume":"109","author":"Ferreon","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2024.102538_bib152","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1021\/acs.biomac.1c00884","article-title":"Cationic carbosilane dendrimers prevent abnormal \u03b1-synuclein accumulation in Parkinson\u2019s disease patient-specific dopamine neurons","volume":"22","author":"Ferrer-Lorente","year":"2021","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.arr.2024.102538_bib153","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0076-6879(99)09019-9","article-title":"Analysis of protein aggregation kinetics","volume":"309","author":"Ferrone","year":"1999","journal-title":"Methods Enzym."},{"key":"10.1016\/j.arr.2024.102538_bib154","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3389\/fnmol.2019.00299","article-title":"Targeting alpha-synuclein as a therapy for Parkinson\u2019s disease","volume":"12","author":"Fields","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib155","unstructured":"filaments assembled from C-terminally, S., truncated alpha-synuclein; RA Crowther, R Jakes, MG Spillantini, M Goedert. FEBS Letters, 309-312. (2024)."},{"key":"10.1016\/j.arr.2024.102538_bib156","first-page":"105","article-title":"The compound ATH434 prevents alpha-synuclein toxicity in a murine model of multiple system atrophy","volume":"12","author":"Finkelstein","year":"2022","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.arr.2024.102538_bib157","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s11064-015-1597-y","article-title":"Stabilization of alpha-synuclein oligomers in vitro by the neurotransmitters, dopamine and norepinephrine: the effect of oxidized catecholamines","volume":"40","author":"Fischer","year":"2015","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.arr.2024.102538_bib158","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1089\/acm.1999.5.57","article-title":"Evidence of functional zinc deficiency in Parkinson's disease","volume":"5","author":"Forsleff","year":"1999","journal-title":"J. Altern. Complement. Med."},{"key":"10.1016\/j.arr.2024.102538_bib159","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/jnr.21125","article-title":"RNA interference-mediated knockdown of \u03b1-synuclein protects human dopaminergic neuroblastoma cells from MPP+ toxicity and reduces dopamine transport","volume":"85","author":"Fountaine","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.arr.2024.102538_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175090","article-title":"Effect of glycine transporter 1 inhibition with bitopertin on parkinsonism and L-DOPA induced dyskinesia in the 6-OHDA-lesioned rat","volume":"929","author":"Frouni","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.arr.2024.102538_bib161","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"\u03b1-Synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.arr.2024.102538_bib162","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.bbrc.2005.01.068","article-title":"Contribution of simple saccharides to the stabilization of amyloid structure","volume":"328","author":"Fung","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.arr.2024.102538_bib163","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13506129.2017.1304905","article-title":"ThT 101: a primer on the use of thioflavin T to investigate amyloid formation","volume":"24","author":"Gade Malmos","year":"2017","journal-title":"Amyloid"},{"key":"10.1016\/j.arr.2024.102538_bib164","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2022.113542","article-title":"Hydroxytyrosol and dopamine metabolites: anti-aggregative effect and neuroprotective activity against \u03b1-synuclein-induced toxicity","volume":"171","author":"Gallardo-Fern\u00e1ndez","year":"2023","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.arr.2024.102538_bib165","doi-asserted-by":"crossref","first-page":"9441","DOI":"10.1523\/JNEUROSCI.5314-13.2014","article-title":"Reducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson's disease-like models","volume":"34","author":"Games","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib166","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1747-0285.2008.00741.x","article-title":"The structure of glycosaminoglycans and their interactions with proteins","volume":"72","author":"Gandhi","year":"2008","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.arr.2024.102538_bib167","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10123005","article-title":"Plasma metabolic disturbances in Parkinson's disease patients","volume":"10","author":"Gatarek","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.arr.2024.102538_bib168","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1021\/bi00519a024","article-title":"Thermodynamic and kinetic examination of protein stabilization by glycerol","volume":"20","author":"Gekko","year":"1981","journal-title":"Biochemistry"},{"key":"10.1016\/j.arr.2024.102538_bib169","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau6722","article-title":"A cullin-RING ubiquitin ligase targets exogenous \u03b1-synuclein and inhibits Lewy body\u2013like pathology","volume":"11","author":"Gerez","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.arr.2024.102538_bib170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-23718-3","article-title":"Small molecules attenuate the interplay between conformational fluctuations, early oligomerization and amyloidosis of alpha synuclein","volume":"8","author":"Ghosh","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2024.102538_bib171","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep09228","article-title":"Structure based aggregation studies reveal the presence of helix-rich intermediate during \u03b1-Synuclein aggregation","volume":"5","author":"Ghosh","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2024.102538_bib172","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3390\/molecules27010088","article-title":"Implementing complementary approaches to shape the mechanism of \u03b1-synuclein oligomerization as a model of amyloid aggregation","volume":"27","author":"Giamp\u00e0","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.arr.2024.102538_bib173","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/mds.870060103","article-title":"Neuronal inclusions of Parkinson's disease","volume":"6","author":"Gibb","year":"1991","journal-title":"Mov. Disord.: Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.arr.2024.102538_bib174","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1021\/bm8002557","article-title":"Suppression of insulin aggregation by heparin","volume":"9","author":"Giger","year":"2008","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.arr.2024.102538_bib175","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/mds.870090306","article-title":"Talipexole and adult Gilles de la Tourette's syndrome: double-blind, placebo-controlled clinical trial","volume":"9","author":"Goetz","year":"1994","journal-title":"Mov. Disord.: Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.arr.2024.102538_bib176","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.bbrc.2018.09.111","article-title":"Exploring the Role of Methionine Residues on the Oligomerization and Neurotoxic Properties of DOPAL-Modified-Synuclein","volume":"505","author":"Gon\u00e7alves","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.arr.2024.102538_bib177","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1073\/pnas.0711053105","article-title":"The phosphorylation state of Ser-129 in human \u03b1-synuclein determines neurodegeneration in a rat model of Parkinson disease","volume":"105","author":"Gorbatyuk","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2024.102538_bib178","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1074\/jbc.M114.585703","article-title":"Acceleration of \u03b1-synuclein aggregation by exosomes","volume":"290","author":"Grey","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102538_bib179","article-title":"Recent advances in natural products targeting \u03b1-synuclein aggregation or clearance in Parkinson's disease","author":"Gupta","year":"2023","journal-title":"Eur. J. Med. Chem. Rep."},{"key":"10.1016\/j.arr.2024.102538_bib180","doi-asserted-by":"crossref","first-page":"18666","DOI":"10.1074\/jbc.270.31.18666","article-title":"Proteoglycan-mediated inhibition of A\u03b2 proteolysis: a potential cause of senile plaque accumulation","volume":"270","author":"Gupta-Bansal","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102538_bib181","article-title":"Olfactory loss in Parkinson's disease","volume":"2011","author":"Haehner","year":"2011","journal-title":"Park. \u2019S. Dis."},{"key":"10.1016\/j.arr.2024.102538_bib182","doi-asserted-by":"crossref","first-page":"17726","DOI":"10.1073\/pnas.1315654110","article-title":"Synthetic polyubiquitinated \u03b1-Synuclein reveals important insights into the roles of the ubiquitin chain in regulating its pathophysiology","volume":"110","author":"Haj-Yahya","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2024.102538_bib183","doi-asserted-by":"crossref","DOI":"10.14283\/jpad.2017.22","article-title":"Evaluation of the neuroprotective potential of N-acetylcysteine for prevention and treatment of cognitive aging and dementia","author":"Hara","year":"2017","journal-title":"Prev. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.arr.2024.102538_bib184","article-title":"Excessive early-life dietary exposure: a potential source of elevated brain iron and a risk factor for Parkinson\u2019s disease","volume":"3","author":"Hare","year":"2017","journal-title":"npj Park. 'S. Dis."},{"key":"10.1016\/j.arr.2024.102538_bib185","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3389\/fnins.2019.00654","article-title":"Manganese-induced neurotoxicity: new insights into the triad of protein misfolding, mitochondrial impairment, and neuroinflammation","volume":"13","author":"Harischandra","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib186","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aau4543","article-title":"Manganese promotes the aggregation and prion-like cell-to-cell exosomal transmission of \u03b1-synuclein","volume":"12","author":"Harischandra","year":"2019","journal-title":"Sci. Signal."},{"key":"10.1016\/j.arr.2024.102538_bib187","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.parkreldis.2018.08.024","article-title":"Rasagiline monotherapy in early Parkinson's disease: a phase 3, randomized study in Japan","volume":"60","author":"Hattori","year":"2019","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.arr.2024.102538_bib188","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1365-2990.2007.00874.x","article-title":"Parkinson's disease: a dual-hit hypothesis","volume":"33","author":"Hawkes","year":"2007","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.arr.2024.102538_bib189","doi-asserted-by":"crossref","first-page":"207","DOI":"10.37349\/ent.2023.00048","article-title":"Targeting \u03b1-synuclein aggregation with immunotherapy: a promising therapeutic approach for Parkinson\u2019s disease","author":"Henriquez","year":"2023","journal-title":"Explor. Neuroprotective Ther. 3"},{"key":"10.1016\/j.arr.2024.102538_bib190","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1021\/acschemneuro.0c00381","article-title":"Potential role of natural polyphenols against protein aggregation toxicity: in vitro, in vivo, and clinical studies","volume":"11","author":"Henr\u00edquez","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib191","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2024.168615","article-title":"Interplay of Proteostasis Capacity and Protein Aggregation: Implications for Cellular Function and Disease","author":"Hipp","year":"2024","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.arr.2024.102538_bib192","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.expneurol.2009.03.003","article-title":"Anti-aggregation and fibril-destabilizing effects of sex hormones on \u03b1-synuclein fibrils in vitro","volume":"217","author":"Hirohata","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.arr.2024.102538_bib193","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1021\/acschemneuro.2c00362","article-title":"Inhibition of \u03b1-Synuclein Seeding-Dependent Aggregation by ssDNA Aptamers Specific to C-Terminally Truncated \u03b1-Synuclein Fibrils","volume":"13","author":"Hmila","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib194","doi-asserted-by":"crossref","first-page":"47746","DOI":"10.1074\/jbc.M408906200","article-title":"Functional consequences of \u03b1-synuclein tyrosine nitration: diminished binding to lipid vesicles and increased fibril formation","volume":"279","author":"Hodara","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102538_bib195","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.bbapap.2008.09.026","article-title":"Smoking and Parkinson's disease: does nicotine affect \u03b1-synuclein fibrillation?","volume":"1794","author":"Hong","year":"2009","journal-title":"Biochim. Et. Biophys. Acta (BBA)-Proteins Proteom."},{"key":"10.1016\/j.arr.2024.102538_bib196","doi-asserted-by":"crossref","first-page":"7722","DOI":"10.1021\/acs.jafc.6b03217","article-title":"Protocatechuic acid: inhibition of fibril formation, destabilization of preformed fibrils of amyloid-\u03b2 and \u03b1-synuclein, and neuroprotection","volume":"64","author":"Hornedo-Ortega","year":"2016","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.arr.2024.102538_bib197","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00726-018-2547-1","article-title":"Taurine protects noradrenergic locus coeruleus neurons in a mouse Parkinson\u2019s disease model by inhibiting microglial M1 polarization","volume":"50","author":"Hou","year":"2018","journal-title":"Amino Acids"},{"key":"10.1016\/j.arr.2024.102538_bib198","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0022-2836(02)00775-1","article-title":"Dependence of \u03b1-synuclein aggregate morphology on solution conditions","volume":"322","author":"Hoyer","year":"2002","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.arr.2024.102538_bib199","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1212\/WNL.57.4.626","article-title":"Brain metabolite concentration and dementia severity in Alzheimer\u2019s disease: a 1H MRS study","volume":"57","author":"Huang","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2024.102538_bib200","article-title":"Nicotine Ameliorates \u03b1-synuclein Pre-formed Fibril-Induced Behavioral Deficits and Pathological Features in Mice","volume":"2024","author":"Huang","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.arr.2024.102538_bib201","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fnins.2019.00028","article-title":"\u03b1-Synuclein: a multifunctional player in exocytosis, endocytosis, and vesicle recycling","volume":"13","author":"Huang","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib202","doi-asserted-by":"crossref","first-page":"8202","DOI":"10.1021\/bi200760h","article-title":"Designed hairpin peptides interfere with amyloidogenesis pathways: fibril formation and cytotoxicity inhibition, interception of the preamyloid state","volume":"50","author":"Huggins","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.arr.2024.102538_bib203","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00401-018-1907-y","article-title":"Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating role in Parkinson\u2019s disease pathogenesis","volume":"137","author":"Hughes","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2024.102538_bib204","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/B978-0-12-411464-7.00010-9","article-title":"Operationalization of global Alzheimer\u2019s disease trials","author":"Hughes","year":"2014","journal-title":"Glob. Clin. Trials Alzheimer'S. Dis."},{"key":"10.1016\/j.arr.2024.102538_bib205","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.bbrc.2015.12.043","article-title":"\u03b1-Synuclein aggregation, seeding and inhibition by scyllo-inositol","volume":"469","author":"Ibrahim","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.arr.2024.102538_bib206","doi-asserted-by":"crossref","DOI":"10.1016\/j.onano.2023.100140","article-title":"PAMAM dendrimers of generation 4.5 loaded with curcumin interfere with \u03b1-synuclein aggregation","volume":"11","author":"Igart\u00faa","year":"2023","journal-title":"OpenNano"},{"key":"10.1016\/j.arr.2024.102538_bib207","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.3390\/ijms23031862","article-title":"Central nervous system stimulants limit caffeine transport at the blood\u2013cerebrospinal fluid barrier","volume":"23","author":"Ikeda-Murakami","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102538_bib208","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3389\/fnins.2016.00408","article-title":"Alpha-synuclein oligomers\u2014neurotoxic molecules in Parkinson's disease and other Lewy body disorders","volume":"10","author":"Ingelsson","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib209","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1212\/01.wnl.0000201252.57661.e1","article-title":"A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease","volume":"66","author":"Investigators","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2024.102538_bib210","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1093\/hmg\/ddg283","article-title":"Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies","volume":"12","author":"Iwata","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.arr.2024.102538_bib211","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1016\/j.bpj.2019.09.046","article-title":"Effect of osmolytes on conformational behavior of intrinsically disordered protein \u03b1-synuclein","volume":"117","author":"Jahan","year":"2019","journal-title":"Biophys. J."},{"key":"10.1016\/j.arr.2024.102538_bib212","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1124\/pharmrev.120.000133","article-title":"Therapeutics in the pipeline targeting \u03b1-synuclein for Parkinson's disease","volume":"74","author":"Jasutkar","year":"2022","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.arr.2024.102538_bib213","article-title":"Novel multifunctional nanoliposomes inhibit \u03b1-synuclein fibrillization, attenuate microglial activation, and silence the expression of SNCA gene","author":"Jebali","year":"2021","journal-title":"Neurol. \u00eda"},{"key":"10.1016\/j.arr.2024.102538_bib214","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3389\/fnins.2019.01124","article-title":"Different heat shock proteins bind \u03b1-Synuclein with distinct mechanisms and synergistically prevent its amyloid aggregation","volume":"13","author":"Jia","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib215","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1021\/acs.jafc.9b00922","article-title":"Dihydromyricetin inhibits \u03b1-synuclein aggregation, disrupts preformed fibrils, and protects neuronal cells in culture against amyloid-induced cytotoxicity","volume":"67","author":"Jia","year":"2019","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.arr.2024.102538_bib216","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.biopha.2018.06.162","article-title":"Cellular phenotypes as inflammatory mediators in Parkinson\u2019s disease: interventional targets and role of natural products","volume":"106","author":"Jiang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.arr.2024.102538_bib217","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1523\/JNEUROSCI.5634-10.2011","article-title":"\u03b1-Synuclein negatively regulates protein kinase C\u03b4 expression to suppress apoptosis in dopaminergic neurons by reducing p300 histone acetyltransferase activity","volume":"31","author":"Jin","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib218","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.bbamcr.2006.12.009","article-title":"The c-jun kinase\/stress-activated pathway: regulation, function and role in human disease","volume":"1773","author":"Johnson","year":"2007","journal-title":"Biochim. Et. Biophys. Acta -Mol. Cell Res."},{"key":"10.1016\/j.arr.2024.102538_bib219","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00792-016-0828-8","article-title":"Potential applications of stress solutes from extremophiles in protein folding diseases and healthcare","volume":"20","author":"Jorge","year":"2016","journal-title":"Extremophiles"},{"key":"10.1016\/j.arr.2024.102538_bib220","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.1523\/JNEUROSCI.6119-09.2010","article-title":"Methylation regulates alpha-synuclein expression and is decreased in Parkinson's disease patients' brains","volume":"30","author":"Jowaed","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib221","doi-asserted-by":"crossref","DOI":"10.1103\/PhysRevLett.121.038101","article-title":"Water-mediated protein-protein interactions at high pressures are controlled by a deep-sea osmolyte","volume":"121","author":"Julius","year":"2018","journal-title":"Phys. Rev. Lett."},{"key":"10.1016\/j.arr.2024.102538_bib222","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0014-2999(01)00902-5","article-title":"Release and aggregation of cytochrome c and \u03b1-synuclein are inhibited by the antiparkinsonian drugs, talipexole and pramipexole","volume":"417","author":"Kakimura","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.arr.2024.102538_bib223","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.bbamem.2018.01.015","article-title":"Serum albumin impedes the amyloid aggregation and hemolysis of human islet amyloid polypeptide and alpha synuclein","volume":"1860","author":"Kakinen","year":"2018","journal-title":"Biochim. Et. Biophys. Acta -Biomembr."},{"key":"10.1016\/j.arr.2024.102538_bib224","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2022.102608","article-title":"Engineered graphene quantum dot nanocomposite triggers \u03b1-synuclein defibrillation: Therapeutics against Parkinson's disease","volume":"47","author":"Kaliyaperumal","year":"2023","journal-title":"Nanomed.: Nanotechnol., Biol. Med."},{"key":"10.1016\/j.arr.2024.102538_bib225","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103092","article-title":"Gut microbiome, short-chain fatty acids, alpha-synuclein, neuroinflammation, and ROS\/RNS: Relevance to Parkinson's disease and therapeutic implications","author":"Kalyanaraman","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.arr.2024.102538_bib226","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1750-3639.2008.00140.x","article-title":"Three-layered structure shared between lewy bodies and lewy neurites\u2014three-dimensional reconstruction of triple-labeled sections","volume":"18","author":"Kanazawa","year":"2008","journal-title":"Brain Pathol."},{"key":"10.1016\/j.arr.2024.102538_bib227","doi-asserted-by":"crossref","first-page":"10773","DOI":"10.1073\/pnas.1713969114","article-title":"TrkB neurotrophic activities are blocked by \u03b1-synuclein, triggering dopaminergic cell death in Parkinson\u2019s disease","volume":"114","author":"Kang","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2024.102538_bib228","doi-asserted-by":"crossref","first-page":"959","DOI":"10.4103\/1673-5374.385303","article-title":"Soluble alpha-synuclein post-translational modifications: unexpected regulators of pathological alpha-synuclein amplification","volume":"19","author":"Kapila","year":"2024","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.arr.2024.102538_bib229","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.202300526","article-title":"Effects of ferulic acid on cognitive function: a systematic review","author":"Karademir","year":"2024","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.arr.2024.102538_bib230","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1021\/acschemneuro.5b00158","article-title":"Understanding caffeine\u2019s role in attenuating the toxicity of \u03b1-synuclein aggregates: Implications for risk of Parkinson\u2019s disease","volume":"6","author":"Kardani","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib231","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.bbadis.2017.02.002","article-title":"Nicotine slows down oligomerisation of \u03b1-synuclein and ameliorates cytotoxicity in a yeast model of Parkinson's disease","volume":"1863","author":"Kardani","year":"2017","journal-title":"Biochim. Et. Biophys. Acta (BBA)-Mol. Basis Dis."},{"key":"10.1016\/j.arr.2024.102538_bib232","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.bbadis.2017.02.002","article-title":"Nicotine slows down oligomerisation of \u03b1-synuclein and ameliorates cytotoxicity in a yeast model of Parkinson's disease","volume":"1863","author":"Kardani","year":"2017","journal-title":"Biochim. Et. Biophys. Acta -Mol. Basis Dis."},{"key":"10.1016\/j.arr.2024.102538_bib233","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1038\/emboj.2009.257","article-title":"Pre-fibrillar \u03b1-synuclein variants with impaired \u03b2-structure increase neurotoxicity in Parkinson's disease models","volume":"28","author":"Karpinar","year":"2009","journal-title":"EMBO J."},{"key":"10.1016\/j.arr.2024.102538_bib234","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neulet.2008.02.057","article-title":"Cleavage of normal and pathological forms of \u03b1-synuclein by neurosin in vitro","volume":"436","author":"Kasai","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2024.102538_bib235","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1016\/j.bpj.2015.10.010","article-title":"Protein Polymerization into Fibrils from the Viewpoint of Nucleation Theory","volume":"109","author":"Kashchiev","year":"2015","journal-title":"Biophys. J."},{"key":"10.1016\/j.arr.2024.102538_bib236","doi-asserted-by":"crossref","first-page":"06B602","DOI":"10.1063\/1.3447891","article-title":"Nucleation of amyloid fibrils","volume":"132","author":"Kashchiev","year":"2010","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.arr.2024.102538_bib237","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1021\/acschemneuro.8b00056","article-title":"Paradoxical effect of trehalose on the aggregation of \u03b1-synuclein: expedites onset of aggregation yet reduces fibril load","volume":"9","author":"Katyal","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib238","doi-asserted-by":"crossref","first-page":"77706","DOI":"10.1039\/C5RA13546J","article-title":"Potential role of protein stabilizers in amelioration of Parkinson's disease and associated effects in transgenic Caenorhabditis elegans model expressing alpha-synuclein","volume":"5","author":"Kaur","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.arr.2024.102538_bib239","doi-asserted-by":"crossref","first-page":"7058","DOI":"10.1021\/jp981119l","article-title":"Thermal stability of proteins in aqueous polyol solutions: role of the surface tension of water in the stabilizing effect of polyols","volume":"102","author":"Kaushik","year":"1998","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.arr.2024.102538_bib240","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102113","article-title":"Recent advancement in therapeutic strategies for Alzheimer\u2019s disease: insights from clinical trials","author":"Khan","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2024.102538_bib241","doi-asserted-by":"crossref","DOI":"10.1021\/acsomega.4c00595","article-title":"Understanding the modulation of \u03b1-synuclein fibrillation by n-acetyl aspartate: a brain metabolite","author":"Khan","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.arr.2024.102538_bib242","series-title":"Effects of a Unilateral Injection of Botulinum Neurotoxin Subtype-A in the Subthalamic Nucleus of a Parkinsonian Rat Model","article-title":"Effects of a unilateral injection of botulinum neurotoxin subtype-A in the subthalamic nucleus of a Parkinsonian rat model","author":"Khazov","year":"2019"},{"key":"10.1016\/j.arr.2024.102538_bib243","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.562241","article-title":"The role of lipids in the initiation of \u03b1-synuclein misfolding","volume":"8","author":"Kiechle","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.arr.2024.102538_bib244","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.2353\/ajpath.2007.070231","article-title":"Minocycline modulates neuroinflammation independently of its antimicrobial activity in Staphylococcus aureus-induced brain abscess","volume":"171","author":"Kielian","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.arr.2024.102538_bib245","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1021\/cb400017h","article-title":"Chemical induction of Hsp70 reduces \u03b1-synuclein aggregation in neuroglioma cells","volume":"8","author":"Kilpatrick","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.arr.2024.102538_bib246","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-5-20","article-title":"The inhibitory effect of pyrroloquinoline quinone on the amyloid formation and cytotoxicity of truncated alpha-synuclein","volume":"5","author":"Kim","year":"2010","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2024.102538_bib247","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3233\/JAD-2010-100183","article-title":"Regulation of in vitro A\u03b2 1-40 aggregation mediated by small molecules","volume":"22","author":"Kim","year":"2010","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.arr.2024.102538_bib248","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.bbrc.2009.07.083","article-title":"\u03b2-Sheet-breaking peptides inhibit the fibrillation of human \u03b1-synuclein","volume":"387","author":"Kim","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.arr.2024.102538_bib249","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/s41565-018-0179-y","article-title":"Graphene quantum dots prevent \u03b1-synucleinopathy in Parkinson\u2019s disease","volume":"13","author":"Kim","year":"2018","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.arr.2024.102538_bib250","doi-asserted-by":"crossref","first-page":"25497","DOI":"10.1074\/jbc.M400255200","article-title":"Hsp70 reduces \u03b1-synuclein aggregation and toxicity","volume":"279","author":"Klucken","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102538_bib251","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00424-014-1454-x","article-title":"T-type calcium channel blockers as neuroprotective agents","volume":"466","author":"Kopecky","year":"2014","journal-title":"Pfl\u00fcgers Arch. -Eur. J. Physiol."},{"key":"10.1016\/j.arr.2024.102538_bib252","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/mds.870130303","article-title":"Neuropathology of fetal nigral grafts in patients with Parkinson's disease","volume":"13","author":"Kordower","year":"1998","journal-title":"Mov. Disord.: Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.arr.2024.102538_bib253","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF00314594","article-title":"Diffuse Lewy body disease in Japan","volume":"237","author":"Kosaka","year":"1990","journal-title":"J. Neurol."},{"key":"10.1016\/j.arr.2024.102538_bib254","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF00314594","article-title":"Diffuse Lewy body disease in Japan","volume":"237","author":"Kosaka","year":"1990","journal-title":"J. Neurol."},{"key":"10.1016\/j.arr.2024.102538_bib255","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41598-017-18443-2","article-title":"Mechanistic insights into remodeled Tau-derived PHF6 peptide fibrils by Naphthoquinone-Tryptophan hybrids","volume":"8","author":"KrishnaKumar","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2024.102538_bib256","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1021\/bi026528t","article-title":"Oxidative dimer formation is the critical rate-limiting step for Parkinson's disease \u03b1-synuclein fibrillogenesis","volume":"42","author":"Krishnan","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.arr.2024.102538_bib257","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/1028415X.2017.1354543","article-title":"Pharmacological effects of protocatechuic acid and its therapeutic potential in neurodegenerative diseases: Review on the basis of in vitro and in vivo studies in rodents and humans","volume":"22","author":"Krzysztoforska","year":"2019","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib258","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2009.09.007","article-title":"Role of naturally occurring osmolytes in protein folding and stability","volume":"491","author":"Kumar","year":"2009","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.arr.2024.102538_bib259","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bpc.2012.11.004","article-title":"Structure and effect of sarcosine on water and urea by using molecular dynamics simulations: Implications in protein stabilization","volume":"171","author":"Kumar","year":"2013","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.arr.2024.102538_bib260","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1021\/acschemneuro.1c00001","article-title":"Ellagic acid inhibits \u03b1-synuclein aggregation at multiple stages and reduces its cytotoxicity","volume":"12","author":"Kumar","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib261","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.brainres.2011.12.028","article-title":"Involvement of NADPH oxidase and glutathione in zinc-induced dopaminergic neurodegeneration in rats: similarity with paraquat neurotoxicity","volume":"1438","author":"Kumar","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.arr.2024.102538_bib262","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1021\/acschemneuro.6b00207","article-title":"Delivery of dual drug loaded lipid based nanoparticles across the blood\u2013brain barrier impart enhanced neuroprotection in a rotenone induced mouse model of Parkinson\u2019s disease","volume":"7","author":"Kundu","year":"2016","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib263","doi-asserted-by":"crossref","first-page":"7519","DOI":"10.3390\/ijerph120707519","article-title":"Manganese-induced parkinsonism and Parkinson\u2019s disease: shared and distinguishable features","volume":"12","author":"Kwakye","year":"2015","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.arr.2024.102538_bib264","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1074\/jbc.M113.501635","article-title":"Scyllo-Inositol promotes robust mutant Huntingtin protein degradation","volume":"289","author":"Lai","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102538_bib265","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1021\/acs.biochem.5b01168","article-title":"Stabilization of \u03b1-synuclein fibril clusters prevents fragmentation and reduces seeding activity and toxicity","volume":"55","author":"Lam","year":"2016","journal-title":"Biochemistry"},{"key":"10.1016\/j.arr.2024.102538_bib266","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa2203395","article-title":"Trial of cinpanemab in early Parkinson\u2019s disease","volume":"387","author":"Lang","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arr.2024.102538_bib267","doi-asserted-by":"crossref","first-page":"11915","DOI":"10.1523\/JNEUROSCI.3821-06.2006","article-title":"\u03b1-Synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis","volume":"26","author":"Larsen","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib268","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrn3406","article-title":"The many faces of \u03b1-synuclein: from structure and toxicity to therapeutic target","volume":"14","author":"Lashuel","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib269","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0022-2836(02)00735-0","article-title":"\u03b1-Synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils","volume":"322","author":"Lashuel","year":"2002","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.arr.2024.102538_bib270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-03111-4","article-title":"C-terminal calcium binding of \u03b1-synuclein modulates synaptic vesicle interaction","volume":"9","author":"Lautenschl\u00e4ger","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2024.102538_bib271","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.trecan.2019.10.012","article-title":"The metabolic interplay between cancer and other diseases","volume":"5","author":"Le","year":"2019","journal-title":"Trends Cancer"},{"key":"10.1016\/j.arr.2024.102538_bib272","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3389\/fnmol.2019.00237","article-title":"Voltage-gated calcium channels and \u03b1-synuclein: implications in Parkinson\u2019s disease","volume":"12","author":"Leandrou","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib273","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1460-9568.2009.06873.x","article-title":"The second brain and Parkinson\u2019s disease","volume":"30","author":"Lebouvier","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib274","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1093\/hmg\/ddy143","article-title":"The c-Abl inhibitor, Radotinib HCl, is neuroprotective in a preclinical Parkinson\u2019s disease mouse model","volume":"27","author":"Lee","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.arr.2024.102538_bib275","doi-asserted-by":"crossref","first-page":"7494","DOI":"10.1021\/acs.nanolett.8b02916","article-title":"Mapping surface hydrophobicity of \u03b1-synuclein oligomers at the nanoscale","volume":"18","author":"Lee","year":"2018","journal-title":"Nano Lett."},{"key":"10.1016\/j.arr.2024.102538_bib276","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.biocel.2008.01.017","article-title":"Assembly-dependent endocytosis and clearance of extracellular a-synuclein","volume":"40","author":"Lee","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.arr.2024.102538_bib277","article-title":"Defects in very long chain fatty acid synthesis enhance alpha-synuclein toxicity in a yeast model of Parkinson's disease","volume":"6","author":"Lee","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2024.102538_bib278","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2024.109586","article-title":"Creatine supplementation with exercise reduces \u03b1-synuclein oligomerization and necroptosis in Parkinson's disease mouse model","volume":"126","author":"Leem","year":"2024","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.arr.2024.102538_bib279","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101769","article-title":"Targeting small heat shock proteins to degrade aggregates as a potential strategy in neurodegenerative diseases","volume":"82","author":"Lei","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2024.102538_bib280","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/s42003-021-02624-x","article-title":"Selectivity of Lewy body protein interactions along the aggregation pathway of \u03b1-synuclein","volume":"4","author":"Leit\u00e3o","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.arr.2024.102538_bib281","doi-asserted-by":"crossref","first-page":"8322","DOI":"10.1021\/bi901285x","article-title":"On the mechanism of nonspecific inhibitors of protein aggregation: dissecting the interactions of \u03b1-synuclein with Congo red and lacmoid","volume":"48","author":"Lendel","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.arr.2024.102538_bib282","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1007\/s11064-009-9986-8","article-title":"Modulation of \u03b1-synuclein aggregation by dopamine: a review","volume":"34","author":"Leong","year":"2009","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.arr.2024.102538_bib283","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1021\/cn200072h","article-title":"Ceftriaxone ameliorates motor deficits and protects dopaminergic neurons in 6-hydroxydopamine-lesioned rats","volume":"3","author":"Leung","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib284","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1073\/pnas.1808845116","article-title":"\u03b1-Synuclein O-GlcNAcylation alters aggregation and toxicity, revealing certain residues as potential inhibitors of Parkinson\u2019s disease","volume":"116","author":"Levine","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2024.102538_bib285","series-title":"Methods in enzymology","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0076-6879(99)09020-5","article-title":"[18] Quantification of \u03b2-sheet amyloid fibril structures with thioflavin T","author":"LeVine","year":"1999"},{"key":"10.1016\/j.arr.2024.102538_bib286","doi-asserted-by":"crossref","first-page":"155S","DOI":"10.1592\/phco.27.12part2.155S","article-title":"Overview of Parkinson's disease","volume":"27","author":"Lew","year":"2007","journal-title":"Pharmacother.: J. Hum. Pharmacol. Drug Ther."},{"key":"10.1016\/j.arr.2024.102538_bib287","doi-asserted-by":"crossref","first-page":"16970","DOI":"10.1073\/pnas.1011751107","article-title":"Polyamine pathway contributes to the pathogenesis of Parkinson disease","volume":"107","author":"Lewandowski","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2024.102538_bib288","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1021\/acschembio.7b00113","article-title":"O-GlcNAcylation of \u03b1-synuclein at serine 87 reduces aggregation without affecting membrane binding","volume":"12","author":"Lewis","year":"2017","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.arr.2024.102538_bib289","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-3-19","article-title":"In vivo silencing of alpha-synuclein using naked siRNA","volume":"3","author":"Lewis","year":"2008","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2024.102538_bib290","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1056\/NEJMct0800326","article-title":"Levodopa for the treatment of Parkinson's disease","volume":"359","author":"LeWitt","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arr.2024.102538_bib291","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105962","article-title":"Diagnostic metabolomic profiling of Parkinson's disease biospecimens","volume":"177","author":"LeWitt","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2024.102538_bib292","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1038\/s41467-018-05971-2","article-title":"Cryo-EM of full-length \u03b1-synuclein reveals fibril polymorphs with a common structural kernel","volume":"9","author":"Li","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2024.102538_bib293","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1073\/pnas.0406976102","article-title":"Aggregation promoting C-terminal truncation of \u03b1-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations","volume":"102","author":"Li","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2024.102538_bib294","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102319","article-title":"Modulating \u03b1-synuclein propagation and decomposition: implications in Parkinson's disease therapy","author":"Li","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2024.102538_bib295","first-page":"1","article-title":"Inhibition of \u03b1-synuclein accumulation improves neuronal apoptosis and delayed postoperative cognitive recovery in aged mice","volume":"2021","author":"Li","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.arr.2024.102538_bib296","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/s41422-018-0075-x","article-title":"Amyloid fibril structure of \u03b1-synuclein determined by cryo-electron microscopy","volume":"28","author":"Li","year":"2018","journal-title":"Cell Res."},{"key":"10.1016\/j.arr.2024.102538_bib297","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.chembiol.2004.08.025","article-title":"Rifampicin inhibits \u03b1-synuclein fibrillation and disaggregates fibrils","volume":"11","author":"Li","year":"2004","journal-title":"Chem. Biol."},{"key":"10.1016\/j.arr.2024.102538_bib298","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1110\/ps.051692305","article-title":"The kinetic behavior of insulin fibrillation is determined by heterogeneous nucleation pathways","volume":"14","author":"Librizzi","year":"2005","journal-title":"Protein Sci."},{"key":"10.1016\/j.arr.2024.102538_bib299","doi-asserted-by":"crossref","first-page":"12924","DOI":"10.1074\/jbc.M306390200","article-title":"Proteasomal inhibition by \u03b1-synuclein filaments and oligomers","volume":"279","author":"Lindersson","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102538_bib300","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.bbapap.2014.04.013","article-title":"Gallic acid interacts with \u03b1-synuclein to prevent the structural collapse necessary for its aggregation","volume":"1844","author":"Liu","year":"2014","journal-title":"Biochim. Et. Biophys. Acta -Proteins Proteom."},{"key":"10.1016\/j.arr.2024.102538_bib301","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.128311","article-title":"Recombinant human HspB5-ACD structural domain inhibits neurotoxicity by regulating pathological \u03b1-Syn aggregation","volume":"255","author":"Liu","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.arr.2024.102538_bib302","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/jmcb\/mjr011","article-title":"A novel molecular mechanism for nitrated \u03b1-synuclein-induced cell death","volume":"3","author":"Liu","year":"2011","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.arr.2024.102538_bib303","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00894-023-05513-8","article-title":"Inhibitory mechanism of n-MTAB AuNPs for \u03b1-synuclein aggregation","volume":"29","author":"Liu","year":"2023","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.arr.2024.102538_bib304","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1093\/aje\/kwn273","article-title":"Dietary iron intake and risk of Parkinson's disease","volume":"168","author":"Logroscino","year":"2008","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.arr.2024.102538_bib305","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3723567","article-title":"Ferulic acid exerts neuroprotective effects via autophagy induction in C. elegans and cellular models of Parkinson\u2019s disease","volume":"2022","author":"Long","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.arr.2024.102538_bib306","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1042\/BCJ20170200","article-title":"\u03b1-Synuclein may cross-bridge v-SNARE and acidic phospholipids to facilitate SNARE-dependent vesicle docking","volume":"474","author":"Lou","year":"2017","journal-title":"Biochem. J."},{"key":"10.1016\/j.arr.2024.102538_bib307","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3389\/fnins.2018.00301","article-title":"Chronic caffeine treatment protects against \u03b1-synucleinopathy by reestablishing autophagy activity in the mouse striatum","volume":"12","author":"Luan","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib308","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1038\/s41467-018-04422-2","article-title":"\u03b1-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson\u2019s disease","volume":"9","author":"Ludtmann","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2024.102538_bib309","doi-asserted-by":"crossref","first-page":"21490","DOI":"10.1074\/jbc.M113.545749","article-title":"Soluble, prefibrillar \u03b1-synuclein oligomers promote complex I-dependent, Ca2+-induced mitochondrial dysfunction","volume":"289","author":"Luth","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102538_bib310","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.bbapap.2019.06.006","article-title":"Assembly of \u03b1-synuclein aggregates on phospholipid bilayers","volume":"1867","author":"Lv","year":"2019","journal-title":"Biochim. Et. Biophys. Acta -Proteins Proteom."},{"key":"10.1016\/j.arr.2024.102538_bib311","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.taap.2016.04.009","article-title":"Comparison of the inhibitory effects of tolcapone and entacapone against human UDP-glucuronosyltransferases","volume":"301","author":"Lv","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.arr.2024.102538_bib312","first-page":"686","article-title":"SUMOylation: a novel protein quality control modifier in the heart","author":"Maejima","year":"2014","journal-title":"Am. Heart Assoc."},{"key":"10.1016\/j.arr.2024.102538_bib313","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/mds.23358","article-title":"Reduced but not oxidized cerebrospinal fluid glutathione levels are lowered in Lewy body diseases","volume":"26","author":"Maetzler","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2024.102538_bib314","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1093\/hmg\/ddt674","article-title":"c-Abl phosphorylates \u03b1-synuclein and regulates its degradation: implication for \u03b1-synuclein clearance and contribution to the pathogenesis of Parkinson's disease","volume":"23","author":"Mahul-Mellier","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.arr.2024.102538_bib315","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1038\/cdd.2015.79","article-title":"Fibril growth and seeding capacity play key roles in \u03b1-synuclein-mediated apoptotic cell death","volume":"22","author":"Mahul-Mellier","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.arr.2024.102538_bib316","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.molmed.2012.11.001","article-title":"mTOR: on target for novel therapeutic strategies in the nervous system","volume":"19","author":"Maiese","year":"2013","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.arr.2024.102538_bib317","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.2741\/4861","article-title":"Protein kinases as regulators of osmolyte accumulation under stress conditions: An overview","volume":"25","author":"Manzoor","year":"2020","journal-title":"Front. Bioscience-Landmark"},{"key":"10.1016\/j.arr.2024.102538_bib318","doi-asserted-by":"crossref","first-page":"124506","DOI":"10.1016\/j.molliq.2024.124506","article-title":"Osmolyte-specific counteraction of ethanol-induced aggregation and structure-function distortion of catalase","volume":"400","author":"Manzoor","year":"2024","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.arr.2024.102538_bib319","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1021\/acs.chemrev.8b00532","article-title":"Folding and misfolding of human membrane proteins in health and disease: from single molecules to cellular proteostasis","volume":"119","author":"Marinko","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.arr.2024.102538_bib320","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/cbic.201200478","article-title":"O-GlcNAc modification prevents peptide-dependent acceleration of \u03b1-synuclein aggregation","volume":"13","author":"Marotta","year":"2012","journal-title":"Chembiochem: a Eur. J. Chem. Biol."},{"key":"10.1016\/j.arr.2024.102538_bib321","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/nchem.2361","article-title":"O-GlcNAc modification blocks the aggregation and toxicity of the protein \u03b1-synuclein associated with Parkinson's disease","volume":"7","author":"Marotta","year":"2015","journal-title":"Nat. Chem."},{"key":"10.1016\/j.arr.2024.102538_bib322","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1021\/bi061749a","article-title":"GM1 specifically interacts with \u03b1-synuclein and inhibits fibrillation","volume":"46","author":"Martinez","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.arr.2024.102538_bib323","doi-asserted-by":"crossref","first-page":"10068","DOI":"10.1523\/JNEUROSCI.0896-06.2006","article-title":"Cytosolic catechols inhibit \u03b1-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates","volume":"26","author":"Mazzulli","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib324","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012122","article-title":"\u03b1-synuclein suppression by targeted small interfering RNA in the primate substantia nigra","volume":"5","author":"McCormack","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.arr.2024.102538_bib325","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nm1423","article-title":"Cyclohexanehexol inhibitors of A\u03b2 aggregation prevent and reverse Alzheimer phenotype in a mouse model","volume":"12","author":"McLaurin","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2024.102538_bib326","doi-asserted-by":"crossref","first-page":"12975","DOI":"10.1074\/jbc.RA118.004267","article-title":"Glycosaminoglycans have variable effects on \u03b1-synuclein aggregation and differentially affect the activities of the resulting amyloid fibrils","volume":"293","author":"Mehra","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102538_bib327","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.bbapap.2019.03.001","article-title":"\u03b1-Synuclein misfolding and aggregation: Implications in Parkinson\u2019s disease pathogenesis","volume":"1867","author":"Mehra","year":"2019","journal-title":"Biochim. Et. Biophys. Acta -Protein Proteom."},{"key":"10.1016\/j.arr.2024.102538_bib328","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.bbapap.2019.03.001","article-title":"\u03b1-Synuclein misfolding and aggregation: Implications in Parkinson\u2019s disease pathogenesis","volume":"1867","author":"Mehra","year":"2019","journal-title":"Biochim. Et. Biophys. Acta (BBA)-Proteins Proteom."},{"key":"10.1016\/j.arr.2024.102538_bib329","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nprot.2016.010","article-title":"Molecular mechanisms of protein aggregation from global fitting of kinetic models","volume":"11","author":"Meisl","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.arr.2024.102538_bib330","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2023.102462","article-title":"Islet amyloid polypeptide triggers \u03b1-synuclein pathology in Parkinson\u2019s disease","volume":"226","author":"Meng","year":"2023","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.arr.2024.102538_bib331","doi-asserted-by":"crossref","first-page":"8206","DOI":"10.1021\/bi900506b","article-title":"Molecular mechanisms underlying the flavonoid-induced inhibition of \u03b1-synuclein fibrillation","volume":"48","author":"Meng","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.arr.2024.102538_bib332","article-title":"Effects of various flavonoids on the-synuclein fibrillation process","volume":"2010","author":"Meng","year":"2010","journal-title":"Park. \u2019S. Dis."},{"key":"10.1016\/j.arr.2024.102538_bib333","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.3390\/ijms20153810","article-title":"Lipid and lipid raft alteration in aging and neurodegenerative diseases: a window for the development of new biomarkers","volume":"20","author":"Mesa-Herrera","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102538_bib334","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1161\/01.CIR.51.4.701","article-title":"Circulatory and metabolic effects of glycerol infusion in patients with recent cerebral infarction","volume":"51","author":"Meyer","year":"1975","journal-title":"Circulation"},{"key":"10.1016\/j.arr.2024.102538_bib335","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.ijbiomac.2012.02.003","article-title":"Phosphorus-containing dendrimers against \u03b1-synuclein fibril formation","volume":"50","author":"Milowska","year":"2012","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.arr.2024.102538_bib336","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.ijbiomac.2011.02.021","article-title":"PAMAM G4 dendrimers affect the aggregation of \u03b1-synuclein","volume":"48","author":"Milowska","year":"2011","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.arr.2024.102538_bib337","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.4103\/1673-5374.235013","article-title":"Subcellular localization of alpha-synuclein aggregates and their interaction with membranes","volume":"13","author":"Miraglia","year":"2018","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.arr.2024.102538_bib338","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1002\/anie.201309001","article-title":"Sequestration of a \u03b2-hairpin for control of \u03b1-synuclein aggregation","volume":"53","author":"Mirecka","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.arr.2024.102538_bib339","doi-asserted-by":"crossref","first-page":"7818","DOI":"10.1021\/bi047846q","article-title":"Cleavage of \u03b1-synuclein by calpain: potential role in degradation of fibrillized and nitrated species of \u03b1-synuclein","volume":"44","author":"Mishizen-Eberz","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.arr.2024.102538_bib340","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1126\/science.aaf3934","article-title":"\u03b22-Adrenoreceptor is a regulator of the \u03b1-synuclein gene driving risk of Parkinson\u2019s disease","volume":"357","author":"Mittal","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.arr.2024.102538_bib341","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.126683","article-title":"Structure specific neuro-toxicity of \u03b1-synuclein oligomer","author":"Mondal","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.arr.2024.102538_bib342","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-94175-8","article-title":"Dopamine-loaded nanoparticle systems circumvent the blood\u2013brain barrier restoring motor function in mouse model for Parkinson\u2019s Disease","volume":"11","author":"Monge-Fuentes","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2024.102538_bib343","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/cpt.1548","article-title":"N-acetyl cysteine is associated with dopaminergic improvement in parkinson's disease","volume":"106","author":"Monti","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.arr.2024.102538_bib344","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1021\/acs.joc.9b02641","article-title":"Ubiquitination can change the structure of the \u03b1-synuclein amyloid fiber in a site selective fashion","volume":"85","author":"Moon","year":"2019","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.arr.2024.102538_bib345","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/nn.4641","article-title":"Dopamine induces soluble \u03b1-synuclein oligomers and nigrostriatal degeneration","volume":"20","author":"Mor","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib346","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1110\/ps.24301","article-title":"Solvent-induced collapse of \u03b1-synuclein and acid-denatured cytochrome c","volume":"10","author":"Morar","year":"2001","journal-title":"Protein Sci."},{"key":"10.1016\/j.arr.2024.102538_bib347","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.3390\/ijms21093301","article-title":"Lipids: Key players that modulate \u03b1-synuclein toxicity and neurodegeneration in Parkinson\u2019s disease","volume":"21","author":"Mori","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102538_bib348","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bbapap.2008.10.016","article-title":"Protein aggregation kinetics, mechanism, and curve-fitting: a review of the literature","volume":"1794","author":"Morris","year":"2009","journal-title":"Biochim. Et. Biophys. Acta (BBA)-Proteins Proteom."},{"key":"10.1016\/j.arr.2024.102538_bib349","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.103974","article-title":"Immunotherapy: An emerging treatment option for neurodegenerative diseases","author":"Mukherjee","year":"2024","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.arr.2024.102538_bib350","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1080\/13543784.2023.2263357","article-title":"DNL151, DNL201, and BIIB094: experimental agents for the treatment of Parkinson\u2019s disease","volume":"32","author":"M\u00fcller","year":"2023","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.arr.2024.102538_bib351","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/jamaneurol.2019.4611","article-title":"Ambroxol for the treatment of patients with Parkinson disease with and without glucocerebrosidase gene mutations: a nonrandomized, noncontrolled trial","volume":"77","author":"Mullin","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2024.102538_bib352","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3390\/ijms21020590","article-title":"TGF-\u03b2\/Smad3 signalling modulates GABA neurotransmission: Implications in Parkinson\u2019s disease","volume":"21","author":"Mu\u00f1oz","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102538_bib353","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1006\/bbrc.2000.4253","article-title":"Activated Fyn phosphorylates \u03b1-synuclein at tyrosine residue 125","volume":"280","author":"Nakamura","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.arr.2024.102538_bib354","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1021\/bi0487140","article-title":"Fluorescence studies suggest a role for \u03b1-synuclein in the phosphatidylinositol lipid signaling pathway","volume":"44","author":"Narayanan","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.arr.2024.102538_bib355","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.freeradbiomed.2010.11.027","article-title":"The lipid peroxidation products 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote the formation of \u03b1-synuclein oligomers with distinct biochemical, morphological, and functional properties","volume":"50","author":"N\u00e4sstr\u00f6m","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.arr.2024.102538_bib356","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neuron.2009.12.023","article-title":"Increased expression of \u03b1-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis","volume":"65","author":"Nemani","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2024.102538_bib357","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1021\/bi0485528","article-title":"Ubiquitination of \u03b1-synuclein","volume":"44","author":"Nonaka","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.arr.2024.102538_bib358","doi-asserted-by":"crossref","first-page":"21212","DOI":"10.1074\/jbc.M412621200","article-title":"Reversible inhibition of \u03b1-synuclein fibrillization by dopaminochrome-mediated conformational alterations","volume":"280","author":"Norris","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102538_bib359","doi-asserted-by":"crossref","first-page":"27230","DOI":"10.1074\/jbc.M212436200","article-title":"Effects of oxidative and nitrative challenges on \u03b1-synuclein fibrillogenesis involve distinct mechanisms of protein modifications","volume":"278","author":"Norris","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102538_bib360","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.brainres.2011.01.039","article-title":"Human Polycomb protein 2 promotes \u03b1-synuclein aggregate formation through covalent SUMOylation","volume":"1381","author":"Oh","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.arr.2024.102538_bib361","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.1038\/s41598-022-10789-6","article-title":"Mechanisms of enhanced aggregation and fibril formation of Parkinson\u2019s disease-related variants of \u03b1-synuclein","volume":"12","author":"Ohgita","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2024.102538_bib362","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1074\/jbc.275.1.390","article-title":"Constitutive phosphorylation of the Parkinson's disease associated \u03b1-synuclein","volume":"275","author":"Okochi","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102538_bib363","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.lfs.2007.01.035","article-title":"Blood\u2013brain barrier transport of pramipexole, a dopamine D2 agonist","volume":"80","author":"Okura","year":"2007","journal-title":"Life Sci."},{"key":"10.1016\/j.arr.2024.102538_bib364","doi-asserted-by":"crossref","first-page":"11195","DOI":"10.1074\/jbc.RA118.002780","article-title":"Effects of phosphatidylcholine membrane fluidity on the conformation and aggregation of N-terminally acetylated \u03b1-synuclein","volume":"293","author":"O'Leary","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102538_bib365","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1471-4159.2006.03707.x","article-title":"Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for \u03b1-synuclein fibrils in vitro","volume":"97","author":"Ono","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2024.102538_bib366","doi-asserted-by":"crossref","first-page":"E3945","DOI":"10.1073\/pnas.1309991110","article-title":"Polo-like kinase 2 regulates selective autophagic \u03b1-synuclein clearance and suppresses its toxicity in vivo","volume":"110","author":"Oueslati","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2024.102538_bib367","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006906","article-title":"Dopamine-induced conformational changes in alpha-synuclein","volume":"4","author":"Outeiro","year":"2009","journal-title":"PloS One"},{"key":"10.1016\/j.arr.2024.102538_bib368","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3389\/fneur.2018.00415","article-title":"Are we ready for detecting \u03b1-synuclein prone to aggregation in patients? The case of \u201cprotein-misfolding cyclic amplification\u201d and \u201creal-time quaking-induced conversion\u201d as diagnostic tools","volume":"9","author":"Paciotti","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.arr.2024.102538_bib369","first-page":"503","article-title":"Nilotinib effects in Parkinson\u2019s disease and dementia with Lewy bodies","volume":"6","author":"Pagan","year":"2016","journal-title":"J. Park. 'S. Dis."},{"key":"10.1016\/j.arr.2024.102538_bib370","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa2202867","article-title":"Trial of prasinezumab in early-stage Parkinson\u2019s disease","volume":"387","author":"Pagano","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arr.2024.102538_bib371","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0014-5793(03)00081-4","article-title":"Oxidized glutathione stimulated the amyloid formation of \u03b1-synuclein","volume":"537","author":"Paik","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.arr.2024.102538_bib372","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00401-017-1704-z","article-title":"\u03b1-Synuclein binds to the ER\u2013mitochondria tethering protein VAPB to disrupt Ca 2+ homeostasis and mitochondrial ATP production","volume":"134","author":"Paillusson","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2024.102538_bib373","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1042\/BST0331106","article-title":"\u03b1-Synuclein aggregation in neurodegenerative diseases and its inhibition as a potential therapeutic strategy","volume":"33","author":"Paleologou","year":"2005","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.arr.2024.102538_bib374","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/brain\/awn349","article-title":"Detection of elevated levels of soluble \u03b1-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies","volume":"132","author":"Paleologou","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.arr.2024.102538_bib375","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1523\/JNEUROSCI.5922-09.2010","article-title":"Phosphorylation at S87 is enhanced in synucleinopathies, inhibits \u03b1-synuclein oligomerization, and influences synuclein-membrane interactions","volume":"30","author":"Paleologou","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib376","doi-asserted-by":"crossref","first-page":"21786","DOI":"10.1021\/jacs.0c10054","article-title":"Effects of glutamate arginylation on \u03b1-synuclein: studying an unusual post-translational modification through semisynthesis","volume":"142","author":"Pan","year":"2020","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.arr.2024.102538_bib377","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00401-007-0332-4","article-title":"Curcumin inhibits aggregation of \u03b1-synuclein","volume":"115","author":"Pandey","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2024.102538_bib378","doi-asserted-by":"crossref","first-page":"848","DOI":"10.5012\/bkcs.2012.33.3.848","article-title":"Computational study on oligomer formation of fibril-forming peptide of \u03b1-synuclein","volume":"33","author":"Park","year":"2012","journal-title":"Bull. Korean Chem. Soc."},{"key":"10.1016\/j.arr.2024.102538_bib379","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/mds.25772","article-title":"Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's disease","volume":"29","author":"Parnetti","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2024.102538_bib380","series-title":"Cellular Osmolytes: From Chaperoning Protein Folding to Clinical Perspectives","first-page":"185","article-title":"Potential of Osmolytes as Diagnostic Biomarkers in Various Diseases","author":"Parray","year":"2024"},{"key":"10.1016\/j.arr.2024.102538_bib381","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.3390\/polym14224808","article-title":"Measuring structural changes in cytochrome c under crowded conditions using in vitro and in silico approaches","volume":"14","author":"Parray","year":"2022","journal-title":"Polymers"},{"key":"10.1016\/j.arr.2024.102538_bib382","series-title":"Role of Microbiota Derived Short Chain Fatty Acids in \u03b1-Synuclein Aggregation and Seeding (P5. 092)","article-title":"Role of Microbiota Derived Short Chain Fatty Acids in \u03b1-Synuclein Aggregation and Seeding (P5. 092)","author":"Pasinetti","year":"2017"},{"key":"10.1016\/j.arr.2024.102538_bib383","doi-asserted-by":"crossref","first-page":"7690","DOI":"10.1002\/ange.201400491","article-title":"Co-existence of two different \u03b1-synuclein oligomers with different core structures determined by hydrogen\/deuterium exchange mass spectrometry","volume":"126","author":"Paslawski","year":"2014","journal-title":"Angew. Chem."},{"key":"10.1016\/j.arr.2024.102538_bib384","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41531-022-00322-x","article-title":"Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in protein","volume":"8","author":"Patterson","year":"2022","journal-title":"npj Park. 'S. Dis."},{"key":"10.1016\/j.arr.2024.102538_bib385","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fmolb.2019.00016","article-title":"Novel mannitol-based small molecules for inhibiting aggregation of \u03b1-synuclein amyloids in Parkinson's disease","volume":"6","author":"Paul","year":"2019","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.arr.2024.102538_bib386","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4161\/cib.18483","article-title":"The interaction of Hsc70 protein with fibrillar \u03b1-Synuclein and its therapeutic potential in Parkinson\u2019s disease","volume":"5","author":"Pemberton","year":"2012","journal-title":"Commun. Integr. Biol."},{"key":"10.1016\/j.arr.2024.102538_bib387","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3390\/pharmaceutics15030839","article-title":"Development of small molecules targeting \u03b1-synuclein aggregation: a promising strategy to treat Parkinson\u2019s disease","volume":"15","author":"Pe\u00f1a-D\u00edaz","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.arr.2024.102538_bib388","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.3390\/ijms21103712","article-title":"Unravelling the potential of graphene quantum dots in biomedicine and neuroscience","volume":"21","author":"Perini","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102538_bib389","doi-asserted-by":"crossref","first-page":"E1009","DOI":"10.1073\/pnas.1610586114","article-title":"A natural product inhibits the initiation of \u03b1-synuclein aggregation and suppresses its toxicity","volume":"114","author":"Perni","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2024.102538_bib390","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.parkreldis.2010.08.003","article-title":"Gastrointestinal dysfunction in Parkinson\u2019s disease","volume":"17","author":"Pfeiffer","year":"2011","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.arr.2024.102538_bib391","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.arr.2017.09.006","article-title":"Alpha-synuclein, epigenetics, mitochondria, metabolism, calcium traffic, & circadian dysfunction in Parkinson\u2019s disease. An integrated strategy for management","volume":"40","author":"Phillipson","year":"2017","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2024.102538_bib392","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep24526","article-title":"Structural and functional properties of prefibrillar \u03b1-synuclein oligomers","volume":"6","author":"Pieri","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2024.102538_bib393","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050027","article-title":"Covalent \u03b1-synuclein dimers: chemico-physical and aggregation properties","volume":"7","author":"Pivato","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.arr.2024.102538_bib394","article-title":"Number and Brightness analysis of alpha-synuclein oligomerization and the associated mitochondrial morphology alterations in live cells","volume":"1840","author":"Plotegher","year":"2014","journal-title":"Biochim. Et. Biophys. Acta (BBA)-Gen. Subj."},{"key":"10.1016\/j.arr.2024.102538_bib395","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.659926","article-title":"Identification of two novel peptides that inhibit \u03b1-synuclein toxicity and aggregation","volume":"14","author":"Popova","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib396","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s13311-012-0105-1","article-title":"A novel \u201cmolecular tweezer\u201d inhibitor of \u03b1-synuclein neurotoxicity in vitro and in vivo","volume":"9","author":"Prabhudesai","year":"2012","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.arr.2024.102538_bib397","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2022.114257","article-title":"Biochemical and behavioral effects of rosmarinic acid treatment in an animal model of Parkinson\u2019s disease induced by MPTP","volume":"440","author":"Presti-Silva","year":"2023","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.arr.2024.102538_bib398","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-34490-9","article-title":"The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson\u2019s disease","volume":"8","author":"Price","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2024.102538_bib399","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1124\/jpet.109.158436","article-title":"Brain-permeable small-molecule inhibitors of Hsp90 prevent \u03b1-synuclein oligomer formation and rescue \u03b1-synuclein-induced toxicity","volume":"332","author":"Putcha","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.arr.2024.102538_bib400","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3390\/nu16010085","article-title":"Ellagic Acid Prevents \u03b1-Synuclein Spread and Mitigates Toxicity by Enhancing Autophagic Flux in an Animal Model of Parkinson\u2019s Disease","volume":"16","author":"Radwan","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.arr.2024.102538_bib401","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.3390\/nu14061292","article-title":"Taurine supplementation as a neuroprotective strategy upon brain dysfunction in metabolic syndrome and diabetes","volume":"14","author":"Rafiee","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.arr.2024.102538_bib402","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2023.121909","article-title":"Polyethylene glycol induced structural modulation of holo alpha-lactalbumin: In vitro and in vivo approach towards protein stability","volume":"382","author":"Raina","year":"2023","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.arr.2024.102538_bib403","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/mabi.200800242","article-title":"PAMAM Dendrimers as Potential Agents against Fibrillation of \u03b1-Synuclein, a Parkinson's Disease-Related Protein","volume":"9","author":"Rekas","year":"2009","journal-title":"Macromol. Biosci."},{"issue":"751-754","key":"10.1016\/j.arr.2024.102538_bib404","first-page":"759","article-title":"Quercetin permeability across blood-brain barrier and its effect on the viability of U251 cells. Sichuan da xue xue bao","volume":"41","author":"Ren","year":"2010","journal-title":"Yi xue Ban. = J. Sichuan Univ. Med. Sci. Ed."},{"key":"10.1016\/j.arr.2024.102538_bib405","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.omtn.2019.07.008","article-title":"Exosomal DNA aptamer targeting \u03b1-synuclein aggregates reduced neuropathological deficits in a mouse Parkinson\u2019s disease model","volume":"17","author":"Ren","year":"2019","journal-title":"Mol. Ther. -Nucleic Acids"},{"key":"10.1016\/j.arr.2024.102538_bib406","first-page":"28","article-title":"Protein misfolding and degenerative diseases","volume":"3","author":"Reynaud","year":"2010","journal-title":"Nat. Educ."},{"key":"10.1016\/j.arr.2024.102538_bib407","doi-asserted-by":"crossref","first-page":"19366","DOI":"10.1021\/ja2029848","article-title":"Mechanism of membrane interaction and disruption by \u03b1-synuclein","volume":"133","author":"Reynolds","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.arr.2024.102538_bib408","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fneur.2017.00037","article-title":"Exploring Braak\u2019s hypothesis of Parkinson\u2019s disease","volume":"8","author":"Rietdijk","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.arr.2024.102538_bib409","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nature15368","article-title":"Structure of the toxic core of \u03b1-synuclein from invisible crystals","volume":"525","author":"Rodriguez","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.arr.2024.102538_bib410","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s00018-012-1198-8","article-title":"Alpha-synuclein elicits glucose uptake and utilization in adipocytes through the Gab1\/PI3K\/Akt transduction pathway","volume":"70","author":"Rodriguez-Araujo","year":"2013","journal-title":"Cell. Mol. life Sci."},{"key":"10.1016\/j.arr.2024.102538_bib411","article-title":"Gold nanoparticles crossing blood-brain barrier prevent HSV-1 infection and reduce herpes associated amyloid-\u03b2secretion.","volume":"9","author":"Rodriguez-Izquierdo","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.arr.2024.102538_bib412","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-8-5","article-title":"Aggregation and neurotoxicity of recombinant \u03b1-synuclein aggregates initiated by dimerization","volume":"8","author":"Roostaee","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2024.102538_bib413","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1074\/jbc.M704809200","article-title":"Monoubiquitylation of \u03b1-synuclein by seven in absentia homolog (SIAH) promotes its aggregation in dopaminergic cells","volume":"283","author":"Rott","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102538_bib414","doi-asserted-by":"crossref","first-page":"13176","DOI":"10.1073\/pnas.1704351114","article-title":"SUMOylation and ubiquitination reciprocally regulate \u03b1-synuclein degradation and pathological aggregation","volume":"114","author":"Rott","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2024.102538_bib415","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.bbapap.2018.07.003","article-title":"Effect of polyols on the structure and aggregation of recombinant human \u03b3-Synuclein, an intrinsically disordered protein","volume":"1866","author":"Roy","year":"2018","journal-title":"Biochim. Et. Biophys. Acta -Proteins Proteom."},{"key":"10.1016\/j.arr.2024.102538_bib416","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.plipres.2010.05.004","article-title":"Alpha-synuclein, lipids and Parkinson\u2019s disease","volume":"49","author":"Ruip\u00e9rez","year":"2010","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.arr.2024.102538_bib417","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1021\/cn400149k","article-title":"Ceftriaxone blocks the polymerization of \u03b1-synuclein and exerts neuroprotective effects in vitro","volume":"5","author":"Ruzza","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib418","doi-asserted-by":"crossref","first-page":"14213","DOI":"10.1021\/acsomega.8b00993","article-title":"Tuning the balance between fibrillation and oligomerization of \u03b1-synuclein in the presence of dopamine","volume":"3","author":"Saha","year":"2018","journal-title":"ACS Omega"},{"key":"10.1016\/j.arr.2024.102538_bib419","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/j.neubiorev.2012.06.007","article-title":"The Parkinson's disease-related genes act in mitochondrial homeostasis","volume":"36","author":"Sai","year":"2012","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.arr.2024.102538_bib420","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.3390\/cells10092452","article-title":"Alpha-synuclein and lipids: the elephant in the room?","volume":"10","author":"Sarchione","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.arr.2024.102538_bib421","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/jnc.14461","article-title":"FYCO1 mediates clearance of \u03b1-synuclein aggregates through a Rab7-dependent mechanism","volume":"146","author":"Saridaki","year":"2018","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2024.102538_bib422","article-title":"Effect of trimethylamine-N-oxide on pressure-induced dissolution of hydrophobic solute","volume":"137","author":"Sarma","year":"2012","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.arr.2024.102538_bib423","doi-asserted-by":"crossref","first-page":"16884","DOI":"10.1523\/JNEUROSCI.3967-11.2011","article-title":"Authentically phosphorylated \u03b1-synuclein at Ser129 accelerates neurodegeneration in a rat model of familial Parkinson's disease","volume":"31","author":"Sato","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib424","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12987-022-00336-w","article-title":"Effects of fasudil on blood-brain barrier integrity","volume":"19","author":"Sato","year":"2022","journal-title":"Fluids and Barriers of the CNS"},{"key":"10.1016\/j.arr.2024.102538_bib425","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/mds.26878","article-title":"First-in-human assessment of PRX002, an anti\u2013\u03b1-synuclein monoclonal antibody, in healthy volunteers","volume":"32","author":"Schenk","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2024.102538_bib426","doi-asserted-by":"crossref","first-page":"8362","DOI":"10.1038\/s41598-019-42847-x","article-title":"GM1 ganglioside modifies \u03b1-synuclein toxicity and is neuroprotective in a rat \u03b1-synuclein model of Parkinson\u2019s disease","volume":"9","author":"Schneider","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2024.102538_bib427","doi-asserted-by":"crossref","first-page":"11615","DOI":"10.1002\/ange.201104380","article-title":"Exploring the piezophilic behavior of natural cosolvent mixtures","volume":"123","author":"Schroer","year":"2011","journal-title":"Angew. Chem."},{"key":"10.1016\/j.arr.2024.102538_bib428","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","article-title":"Lewy pathology in Parkinson\u2019s disease consists of crowded organelles and lipid membranes","volume":"22","author":"Shahmoradian","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib429","doi-asserted-by":"crossref","first-page":"17579","DOI":"10.1074\/jbc.M112.434787","article-title":"A blood-brain barrier (BBB) disrupter is also a potent \u03b1-synuclein (\u03b1-syn) aggregation inhibitor: a novel dual mechanism of mannitol for the treatment of Parkinson disease (PD)","volume":"288","author":"Shaltiel-Karyo","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102538_bib430","doi-asserted-by":"crossref","first-page":"47367","DOI":"10.1021\/acsomega.3c07248","article-title":"Nano-Osmolyte Conjugation: Tailoring the Osmolyte-Protein Interactions at the Nanoscale","volume":"8","author":"Sharma","year":"2023","journal-title":"ACS omega"},{"key":"10.1016\/j.arr.2024.102538_bib431","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.freeradbiomed.2019.02.014","article-title":"The deglycase activity of DJ-1 mitigates \u03b1-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease","volume":"135","author":"Sharma","year":"2019","journal-title":"Free Radic. Biol."},{"key":"10.1016\/j.arr.2024.102538_bib432","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0896-6273(03)00024-2","article-title":"The formation of highly soluble oligomers of \u03b1-synuclein is regulated by fatty acids and enhanced in Parkinson's disease","volume":"37","author":"Sharon","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2024.102538_bib433","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3389\/fnagi.2019.00215","article-title":"The association of iron and the pathologies of Parkinson\u2019s diseases in MPTP\/MPP+-induced neuronal degeneration in non-human primates and in cell culture","volume":"11","author":"Shi","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib434","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4236\/jbpc.2012.32017","article-title":"Demonstration of three dopamine molecules bound to \u03b1-synuclein: Implication of oligomerization at the initial stage","author":"Shimotakahara","year":"2012","journal-title":"J. Biophys. Chem. 3"},{"key":"10.1016\/j.arr.2024.102538_bib435","doi-asserted-by":"crossref","first-page":"23727","DOI":"10.1074\/jbc.M503326200","article-title":"The co-chaperone carboxyl terminus of Hsp70-interacting protein (CHIP) mediates \u03b1-synuclein degradation decisions between proteasomal and lysosomal pathways","volume":"280","author":"Shin","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102538_bib436","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.3390\/diagnostics13142322","article-title":"Modulation of Neurotransmitter Pathways and Associated Metabolites by Systemic Silencing of Gut Genes in C. elegans","volume":"13","author":"Shukla","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.arr.2024.102538_bib437","doi-asserted-by":"crossref","first-page":"7239","DOI":"10.1021\/cr400204z","article-title":"High-pressure chemical biology and biotechnology","volume":"114","author":"Silva","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.arr.2024.102538_bib438","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1021\/cn3001203","article-title":"Curcumin modulates \u03b1-synuclein aggregation and toxicity","volume":"4","author":"Singh","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib439","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12937-016-0179-4","article-title":"Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG)","volume":"15","author":"Singh","year":"2015","journal-title":"Nutr. J."},{"key":"10.1016\/j.arr.2024.102538_bib440","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.792","article-title":"A first-in-human oral dose study of mesdopetam (IRL790) to assess its safety, tolerability, and pharmacokinetics in healthy male volunteers","volume":"9","author":"Sj\u00f6berg","year":"2021","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.arr.2024.102538_bib441","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00726-013-1528-7","article-title":"L-arginine induces protein aggregation and transformation of supramolecular structures of the aggregates","volume":"45","author":"Smirnova","year":"2013","journal-title":"Amino Acids"},{"key":"10.1016\/j.arr.2024.102538_bib442","doi-asserted-by":"crossref","first-page":"5544","DOI":"10.1523\/JNEUROSCI.0482-05.2005","article-title":"Synuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cells","volume":"25","author":"Smith","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib443","first-page":"1","article-title":"Effect of reparation of repeat sequences in the human \u03b1-synuclein on fibrillation ability","author":"Sode","year":"2007","journal-title":"Int. J. Biol. Sci. 3"},{"key":"10.1016\/j.arr.2024.102538_bib444","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.40314","article-title":"Translation attenuation by minocycline enhances longevity and proteostasis in old post-stress-responsive organisms","volume":"7","author":"Solis","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.arr.2024.102538_bib445","doi-asserted-by":"crossref","first-page":"10224","DOI":"10.1074\/jbc.REV120.011743","article-title":"The emerging role of \u03b1-synuclein truncation in aggregation and disease","volume":"295","author":"Sorrentino","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102538_bib446","doi-asserted-by":"crossref","DOI":"10.3389\/fddsv.2023.1314077","article-title":"Introduction to small molecule drug discovery and preclinical development","volume":"3","author":"Southey","year":"2023","journal-title":"Front. Drug Discov."},{"key":"10.1016\/j.arr.2024.102538_bib447","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"\u03b1-Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with Lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2024.102538_bib448","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128510","article-title":"Curcumin treatment improves motor behavior in \u03b1-synuclein transgenic mice","volume":"10","author":"Spinelli","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.arr.2024.102538_bib449","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.736978","article-title":"Alpha-synuclein aggregation in Parkinson's disease","volume":"8","author":"Srinivasan","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.arr.2024.102538_bib450","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1177\/1060028020974560","article-title":"Opicapone (Ongentys): A New COMT Inhibitor for the Treatment of Parkinson\u2019s Disease","volume":"55","author":"St. Onge","year":"2021","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.arr.2024.102538_bib451","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.bbadis.2004.08.004","article-title":"Protein misfolding and aggregation: new examples in medicine and biology of the dark side of the protein world","volume":"1739","author":"Stefani","year":"2004","journal-title":"Biochim. Et. Biophys. Acta -Mol. basis Dis."},{"key":"10.1016\/j.arr.2024.102538_bib452","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.sleep.2021.02.038","article-title":"Nelotanserin as symptomatic treatment for rapid eye movement sleep behavior disorder: a double-blind randomized study using video analysis in patients with dementia with Lewy bodies or Parkinson's disease dementia","volume":"81","author":"Stefani","year":"2021","journal-title":"Sleep. Med."},{"key":"10.1016\/j.arr.2024.102538_bib453","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/cdd.2011.53","article-title":"A deadly spread: cellular mechanisms of \u03b1-synuclein transfer","volume":"18","author":"Steiner","year":"2011","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.arr.2024.102538_bib454","doi-asserted-by":"crossref","unstructured":"Stoeber, J., Williams, J.K., Moghe, P.V., Baum, J., 2021. Tannic Acid Inhibits \u03b1-Synuclein Amyloid Fibril Formation via Binding to the Monomer N-terminal Domain. bioRxiv, 2021.2005. 2026.445860.","DOI":"10.1101\/2021.05.26.445860"},{"key":"10.1016\/j.arr.2024.102538_bib455","doi-asserted-by":"crossref","first-page":"a011353","DOI":"10.1101\/cshperspect.a011353","article-title":"Calcium control of neurotransmitter release","volume":"4","author":"S\u00fcdhof","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.arr.2024.102538_bib456","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/bcp.15991","article-title":"Population pharmacokinetics of rotigotine extended-release microspheres for intramuscular injection in patients with early-stage Parkinson's disease.","volume":"90","author":"Sun","year":"2024","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.arr.2024.102538_bib457","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.3390\/biomedicines10123241","article-title":"Synucleins: New Data on Misfolding, Aggregation and Role in Diseases","volume":"10","author":"Surguchov","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.arr.2024.102538_bib458","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101978","article-title":"Truncation or proteolysis of \u03b1-synuclein in Parkinsonism","volume":"90","author":"Suthar","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2024.102538_bib459","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0165-0173(00)00044-8","article-title":"Movement of zinc and its functional significance in the brain","volume":"34","author":"Takeda","year":"2000","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.arr.2024.102538_bib460","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2024.137654","article-title":"Effects of \u03b17 nicotinic acetylcholine receptor agonist against \u03b1-synuclein-induced neurotoxicity","volume":"823","author":"Takizawa","year":"2024","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2024.102538_bib461","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1093\/hmg\/dds132","article-title":"Forkhead box protein p1 is a transcriptional repressor of immune signaling in the CNS: implications for transcriptional dysregulation in Huntington disease","volume":"21","author":"Tang","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.arr.2024.102538_bib462","doi-asserted-by":"crossref","first-page":"15194","DOI":"10.1074\/jbc.M113.457408","article-title":"Lewy Body-like \u03b1-Synuclein Aggregates Resist Degradation and Impair Macroautophagy* \u2666","volume":"288","author":"Tanik","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102538_bib463","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-016-0310-y","article-title":"Fasudil attenuates aggregation of \u03b1-synuclein in models of Parkinson\u2019s disease","volume":"4","author":"Tatenhorst","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.arr.2024.102538_bib464","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1046\/j.1471-4159.1994.62062349.x","article-title":"Extracellular N-acetylaspartate in the rat brain: in vivo determination of basal levels and changes evoked by high K","volume":"62","author":"Taylor","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2024.102538_bib465","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1248\/bpb.b18-00134","article-title":"Impact of nicotine transport across the blood\u2013brain barrier: carrier-mediated transport of nicotine and interaction with central nervous system drugs","volume":"41","author":"Tega","year":"2018","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.arr.2024.102538_bib466","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3390\/nu8060367","article-title":"Piceatannol and other wine stilbenes: a pool of inhibitors against \u03b1-synuclein aggregation and cytotoxicity","volume":"8","author":"Temsamani","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.arr.2024.102538_bib467","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/anie.201502227","article-title":"The \u201cother\u201d inositols and their phosphates: synthesis, biology, and medicine (with recent advances in myo\u2010inositol chemistry)","volume":"55","author":"Thomas","year":"2016","journal-title":"Angewandte Chemie International Edition"},{"key":"10.1016\/j.arr.2024.102538_bib468","doi-asserted-by":"crossref","first-page":"17004","DOI":"10.1073\/pnas.1109356108","article-title":"Ubiquitin ligase Nedd4 promotes \u03b1-synuclein degradation by the endosomal\u2013lysosomal pathway","volume":"108","author":"Tofaris","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2024.102538_bib469","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1021\/acs.biochem.2c00207","article-title":"Modulation of \u03b1-Synuclein Aggregation In Vitro by a DNA Aptamer","volume":"61","author":"Tran","year":"2022","journal-title":"Biochemistry"},{"key":"10.1016\/j.arr.2024.102538_bib470","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/pro.2056","article-title":"N-terminal acetylation is critical for forming \u03b1-helical oligomer of \u03b1-synuclein","volume":"21","author":"Trexler","year":"2012","journal-title":"Protein Sci."},{"key":"10.1016\/j.arr.2024.102538_bib471","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2174\/0929866054696109","article-title":"Why is arginine effective in suppressing aggregation?","volume":"12","author":"Tsumoto","year":"2005","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.arr.2024.102538_bib472","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nsmb.3194","article-title":"Solid-state NMR structure of a pathogenic fibril of full-length human \u03b1-synuclein","volume":"23","author":"Tuttle","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.arr.2024.102538_bib473","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1097\/WNR.0b013e32830b3661","article-title":"Rifampicin reduces \u03b1-synuclein in a transgenic mouse model of multiple system atrophy","volume":"19","author":"Ubhi","year":"2008","journal-title":"Neuroreport"},{"key":"10.1016\/j.arr.2024.102538_bib474","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.3390\/ijms19123722","article-title":"A rapid method for the detection of sarcosine using SPIONs\/Au\/CS\/SOX\/NPs for prostate cancer sensing","volume":"19","author":"Uhlirova","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102538_bib475","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/07391102.2003.10506918","article-title":"A protein-chameleon: conformational plasticity of \u03b1-synuclein, a disordered protein involved in neurodegenerative disorders","volume":"21","author":"Uversky","year":"2003","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.arr.2024.102538_bib476","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.bbapap.2011.03.010","article-title":"Intrinsically disordered proteins may escape unwanted interactions via functional misfolding","volume":"1814","author":"Uversky","year":"2011","journal-title":"Biochim. Et. Biophys. Acta (BBA)-Proteins Proteom."},{"key":"10.1016\/j.arr.2024.102538_bib477","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0014-5793(02)02446-8","article-title":"Accelerated \u03b1-synuclein fibrillation in crowded milieu","volume":"515","author":"Uversky","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.arr.2024.102538_bib478","doi-asserted-by":"crossref","first-page":"10737","DOI":"10.1074\/jbc.M010907200","article-title":"Evidence for a partially folded intermediate in \u03b1-synuclein fibril formation","volume":"276","author":"Uversky","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102538_bib479","doi-asserted-by":"crossref","first-page":"44284","DOI":"10.1074\/jbc.M105343200","article-title":"Metal-triggered structural transformations, aggregation, and fibrillation of human \u03b1-synuclein: a possible molecular link between Parkinson\u2032 s disease and heavy metal exposure","volume":"276","author":"Uversky","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102538_bib480","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-5793(01)03121-0","article-title":"Trimethylamine-N-oxide-induced folding of \u03b1-synuclein","volume":"509","author":"Uversky","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.arr.2024.102538_bib481","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0014-5793(02)02638-8","article-title":"Methionine oxidation inhibits fibrillation of human \u03b1-synuclein in vitro","volume":"517","author":"Uversky","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.arr.2024.102538_bib482","doi-asserted-by":"crossref","first-page":"14630","DOI":"10.3390\/ijms232314630","article-title":"Structural and Biophysical Characterization of Stable Alpha-Synuclein Oligomers","volume":"23","author":"Vaikath","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102538_bib483","doi-asserted-by":"crossref","first-page":"e01672","DOI":"10.1128\/jvi.01672-22","article-title":"Therapeutic trial of anle138b in mouse models of genetic prion disease","volume":"97","author":"Vallabh","year":"2023","journal-title":"J. Virol."},{"key":"10.1016\/j.arr.2024.102538_bib484","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hbm.24857","article-title":"GABAergic changes in the thalamocortical circuit in Parkinson\u2019s disease","volume":"41","author":"van Nuland","year":"2020","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.arr.2024.102538_bib485","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.arr.2019.01.012","article-title":"The prion-like spreading of \u03b1-synuclein: From in vitro to in vivo models of Parkinson\u2019s disease","volume":"50","author":"Vargas","year":"2019","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2024.102538_bib486","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/j.1471-4159.2009.06054.x","article-title":"Inducible over-expression of wild type \u03b1-synuclein in human neuronal cells leads to caspase-dependent non-apoptotic death","volume":"109","author":"Vekrellis","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2024.102538_bib487","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1093\/brain\/awx056","article-title":"Glycation potentiates \u03b1-synuclein-associated neurodegeneration in synucleinopathies","volume":"140","author":"Vicente Miranda","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.arr.2024.102538_bib488","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2019.103416","article-title":"Ginkgolic acid promotes autophagy-dependent clearance of intracellular alpha-synuclein aggregates","volume":"101","author":"Vijayakumaran","year":"2019","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib489","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1096\/fj.07-095398","article-title":"PYM50028, a novel, orally active, nonpeptide neurotrophic factor inducer, prevents and reverses neuronal damage induced by MPP+ in mesencephalic neurons and by MPTP in a mouse model of Parkinson's disease","volume":"22","author":"Visanji","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.arr.2024.102538_bib490","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2023.105281","article-title":"Plasma and cerebrospinal fluid pharmacokinetics of vodobatinib, a neuroprotective c-Abl tyrosine kinase inhibitor for the treatment of Parkinson's disease","volume":"108","author":"Walsh","year":"2023","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.arr.2024.102538_bib491","article-title":"Protein\u2013protein interactions regulating \u03b1-synuclein pathology","author":"Wang","year":"2024","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib492","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2202-13-142","article-title":"Quantitative assessment of gait and neurochemical correlation in a classical murine model of Parkinson\u2019s disease","volume":"13","author":"Wang","year":"2012","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib493","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-50144-x","article-title":"Myricetin suppresses traumatic brain injury-induced inflammatory response via EGFR\/AKT\/STAT pathway","volume":"13","author":"Wang","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2024.102538_bib494","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2337\/db08-0994","article-title":"Site-specific GlcNAcylation of human erythrocyte proteins: potential biomarker (s) for diabetes","volume":"58","author":"Wang","year":"2009","journal-title":"diabetes"},{"key":"10.1016\/j.arr.2024.102538_bib495","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.neuroscience.2007.07.065","article-title":"Changes in hippocampal synapses and learning-memory abilities in age-increasing rats and effects of tetrahydroxystilbene glucoside in aged rats","volume":"149","author":"Wang","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.arr.2024.102538_bib496","doi-asserted-by":"crossref","first-page":"14232","DOI":"10.18632\/aging.103440","article-title":"Minocycline inhibition of microglial rescues nigrostriatal dopaminergic neurodegeneration caused by mutant alpha-synuclein overexpression","volume":"12","author":"Wang","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.arr.2024.102538_bib497","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/s41401-022-01039-6","article-title":"Pharmacological characterization of the small molecule 03A10 as an inhibitor of \u03b1-synuclein aggregation for Parkinson\u2019s disease treatment","volume":"44","author":"Wang","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.arr.2024.102538_bib498","doi-asserted-by":"crossref","first-page":"E3976","DOI":"10.1073\/pnas.1411694111","article-title":"Phosphatidylethanolamine deficiency disrupts \u03b1-synuclein homeostasis in yeast and worm models of Parkinson disease","volume":"111","author":"Wang","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2024.102538_bib499","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00726-021-03104-6","article-title":"Taurine protects dopaminergic neurons in paraquat-induced Parkinson\u2019s disease mouse model through PI3K\/Akt signaling pathways","volume":"54","author":"Wang","year":"2022","journal-title":"Amino Acids"},{"key":"10.1016\/j.arr.2024.102538_bib500","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fnmol.2016.00048","article-title":"Versatile structures of \u03b1-synuclein","volume":"9","author":"Wang","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib501","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.617308","article-title":"Brain metabolite, N-acetylaspartate is a potent protein aggregation inhibitor","volume":"15","author":"Warepam","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib502","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1021\/acs.biochem.9b00629","article-title":"N-terminal acetylation affects \u03b1-synuclein fibril polymorphism","volume":"58","author":"Watson","year":"2019","journal-title":"Biochemistry"},{"key":"10.1016\/j.arr.2024.102538_bib503","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.bbrc.2009.12.079","article-title":"Residue Glu83 plays a major role in negatively regulating \u03b1-synuclein amyloid formation","volume":"391","author":"Waxman","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.arr.2024.102538_bib504","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.2217\/nnm-2018-0040","article-title":"Factors relating to the biodistribution & clearance of nanoparticles & their effects on in vivo application","volume":"13","author":"Wei","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.arr.2024.102538_bib505","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.nbd.2018.10.016","article-title":"Development of an aggregate-selective, human-derived \u03b1-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson's disease models","volume":"124","author":"Weihofen","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2024.102538_bib506","doi-asserted-by":"crossref","first-page":"13709","DOI":"10.1021\/bi961799n","article-title":"NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded","volume":"35","author":"Weinreb","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.arr.2024.102538_bib507","first-page":"1","article-title":"A Phase I, Randomized, SAD, MAD, and PK Study of Risvodetinib in Older Adults and Parkinson\u2019s Disease","author":"Werner","year":"2024","journal-title":"J. Park. 'S. Dis."},{"key":"10.1016\/j.arr.2024.102538_bib508","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101397","article-title":"Western diet as a trigger of Alzheimer\u2019s disease: From metabolic syndrome and systemic inflammation to neuroinflammation and neurodegeneration","volume":"70","author":"Wi\u0119ckowska-Gacek","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2024.102538_bib509","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.1100976108","article-title":"In vivo demonstration that \u03b1-synuclein oligomers are toxic","volume":"108","author":"Winner","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2024.102538_bib510","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s12035-012-8325-2","article-title":"Molecular chaperones, alpha-synuclein, and neurodegeneration","volume":"47","author":"Witt","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2024.102538_bib511","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.bpj.2018.08.023","article-title":"Intramolecular diffusion in \u03b1-synuclein: It depends on how you measure it","volume":"115","author":"Woodard","year":"2018","journal-title":"Biophys. J."},{"key":"10.1016\/j.arr.2024.102538_bib512","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1093\/brain\/aww238","article-title":"A de novo compound targeting \u03b1-synuclein improves deficits in models of Parkinson\u2019s disease","volume":"139","author":"Wrasidlo","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.arr.2024.102538_bib513","doi-asserted-by":"crossref","DOI":"10.1088\/1478-3975\/abb6dc","article-title":"O-GlcNAcylation inhibits the oligomerization of alpha-synuclein by declining intermolecular hydrogen bonds through a steric effect","volume":"18","author":"Wu","year":"2020","journal-title":"Phys. Biol."},{"key":"10.1016\/j.arr.2024.102538_bib514","first-page":"2654","article-title":"Curcumin protects from oxidative stress and inhibits \u03b1-synuclein aggregation in MPTP induced parkinsonian mice","volume":"9","author":"Xia","year":"2016","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.arr.2024.102538_bib515","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/jnc.14312","article-title":"Iron promotes \u03b1-synuclein aggregation and transmission by inhibiting TFEB-mediated autophagosome-lysosome fusion","volume":"145","author":"Xiao","year":"2018","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2024.102538_bib516","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3390\/biom13050726","article-title":"Distinct effects of familial Parkinson\u2019s disease-associated mutations on \u03b1-synuclein phase separation and amyloid aggregation","volume":"13","author":"Xu","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.arr.2024.102538_bib517","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202200216","article-title":"Myricetin Inhibits \u03b1-Synuclein Amyloid Aggregation by Delaying the Liquid-to-Solid Phase Transition","volume":"23","author":"Xu","year":"2022","journal-title":"Chembiochem"},{"key":"10.1016\/j.arr.2024.102538_bib518","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1021\/bm3003539","article-title":"Effect of heparin on protein aggregation: inhibition versus promotion","volume":"13","author":"Xu","year":"2012","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.arr.2024.102538_bib519","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ymgme.2010.12.014","article-title":"Accumulation and distribution of \u03b1-synuclein and ubiquitin in the CNS of Gaucher disease mouse models","volume":"102","author":"Xu","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.arr.2024.102538_bib520","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1007\/s11064-016-1995-9","article-title":"Epigallocatechin gallate (EGCG) inhibits alpha-synuclein aggregation: A potential agent for Parkinson\u2019s disease","volume":"41","author":"Xu","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.arr.2024.102538_bib521","first-page":"1","article-title":"Effects of the Polyphenols Delphinidin and Rosmarinic Acid on the Inducible Intra-cellular Aggregation of Alpha-Synuclein in Model Neuron Cells","author":"Yamamoto","year":"2023","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.arr.2024.102538_bib522","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0014-5793(03)00367-3","article-title":"Nitration inhibits fibrillation of human \u03b1-synuclein in vitro by formation of soluble oligomers","volume":"542","author":"Yamin","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.arr.2024.102538_bib523","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.927625","article-title":"Identification of gut metabolites associated with Parkinson\u2019s disease using bioinformatic analyses","volume":"14","author":"Yan","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2024.102538_bib524","doi-asserted-by":"crossref","first-page":"R198","DOI":"10.1152\/ajpregu.1990.258.1.R198","article-title":"Counteracting effects of urea and betaine in mammalian cells in culture","volume":"258","author":"Yancey","year":"1990","journal-title":"Am. J. Physiol. -Regul., Integr. Comp. Physiol."},{"key":"10.1016\/j.arr.2024.102538_bib525","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1242\/jeb.114355","article-title":"Co-evolution of proteins and solutions: protein adaptation versus cytoprotective micromolecules and their roles in marine organisms","volume":"218","author":"Yancey","year":"2015","journal-title":"J. Exp. Biol."},{"key":"10.1016\/j.arr.2024.102538_bib526","first-page":"969","article-title":"Fasudil promotes \u03b1-synuclein clearance in an AAV-mediated \u03b1-synuclein rat model of Parkinson\u2019s disease by autophagy activation","volume":"10","author":"Yang","year":"2020","journal-title":"J. Park. 'S. Dis."},{"key":"10.1016\/j.arr.2024.102538_bib527","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.1021\/la400266u","article-title":"Study of wild-type \u03b1-synuclein binding and orientation on gold nanoparticles","volume":"29","author":"Yang","year":"2013","journal-title":"Langmuir"},{"key":"10.1016\/j.arr.2024.102538_bib528","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105218","article-title":"Exosome-mediated delivery of antisense oligonucleotides targeting \u03b1-synuclein ameliorates the pathology in a mouse model of Parkinson's disease","volume":"148","author":"Yang","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2024.102538_bib529","article-title":"EGCG attenuates \u03b1-synuclein protofibril-membrane interactions and disrupts the protofibril","author":"Yang","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.arr.2024.102538_bib530","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.123194","article-title":"EGCG attenuates \u03b1-synuclein protofibril-membrane interactions and disrupts the protofibril","volume":"230","author":"Yang","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.arr.2024.102538_bib531","doi-asserted-by":"crossref","DOI":"10.1038\/srep38510","article-title":"Inhibition of alpha-synuclein aggregation by multifunctional dopamine agonists assessed by a novel in vitro assay and an in vivo Drosophila synucleinopathy model","volume":"6","author":"Yedlapudi","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2024.102538_bib532","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1212\/WNL.63.7_suppl_2.S32","article-title":"A review of the mechanisms and role of monoamine oxidase inhibitors in Parkinson\u2019s disease","volume":"63","author":"Youdim","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2024.102538_bib533","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cbpa.2017.06.008","article-title":"Small molecule probes of protein aggregation","volume":"39","author":"Young","year":"2017","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.arr.2024.102538_bib534","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1002\/mds.29016","article-title":"A Randomized First-in-Human Study With UB-312, a UBITh\u00ae \u03b1-Synuclein Peptide Vaccine","volume":"37","author":"Yu","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2024.102538_bib535","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14393","article-title":"GV-971 attenuates \u03b1-Synuclein aggregation and related pathology","volume":"30","author":"Yu","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.arr.2024.102538_bib536","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-020-01955-6","article-title":"Ablation of polyamine catabolic enzymes provokes Purkinje cell damage, neuroinflammation, and severe ataxia","volume":"17","author":"Zahedi","year":"2020","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.arr.2024.102538_bib537","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1042\/BCJ20190705","article-title":"Scutellarin inhibits the uninduced and metal-induced aggregation of \u03b1-Synuclein and disaggregates preformed fibrils: implications for Parkinson's disease","volume":"477","author":"Zaidi","year":"2020","journal-title":"Biochem. J."},{"key":"10.1016\/j.arr.2024.102538_bib538","article-title":"Structural and Dynamic Insights Into \u03b1-Synuclein Dimer Conformations","author":"Zamel","year":"2019","journal-title":"bioRxiv"},{"key":"10.1016\/j.arr.2024.102538_bib539","doi-asserted-by":"crossref","first-page":"6989","DOI":"10.2147\/IJN.S220380","article-title":"Cerium oxide NPs mitigate the amyloid formation of \u03b1-synuclein and associated cytotoxicity","author":"Zand","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.arr.2024.102538_bib540","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1080\/10715760500233113","article-title":"Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease","volume":"39","author":"Zbarsky","year":"2005","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.arr.2024.102538_bib541","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1248\/bpb.32.1866","article-title":"Protocatechuic acid inhibits rat pheochromocytoma cell damage induced by a dopaminergic neurotoxin","volume":"32","author":"Zhang","year":"2009","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.arr.2024.102538_bib542","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neulet.2010.03.016","article-title":"Protocatechuic acid inhibits neurotoxicity induced by MPTP in vivo","volume":"474","author":"Zhang","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2024.102538_bib543","first-page":"195","article-title":"Quercetin exerts a neuroprotective effect through inhibition of the iNOS\/NO system and pro-inflammation gene expression in PC12 cells and in zebrafish","volume":"27","author":"Zhang","year":"2011","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.arr.2024.102538_bib544","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129564","article-title":"The potential of Rhein's aromatic amines for Parkinson's disease prevention and treatment: \u03b1-Synuclein aggregation inhibition and disaggregation of preformed fibers","volume":"97","author":"Zhang","year":"2024","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.arr.2024.102538_bib545","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1139\/cjpp-2016-0209","article-title":"Tetrahydroxystilbene glucoside inhibits \u03b1-synuclein aggregation and apoptosis in A53T \u03b1-synuclein-transfected cells exposed to MPP","volume":"95","author":"Zhang","year":"2017","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.arr.2024.102538_bib546","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104538","article-title":"Caffeic acid reduces A53T \u03b1-synuclein by activating JNK\/Bcl-2-mediated autophagy in vitro and improves behaviour and protects dopaminergic neurons in a mouse model of Parkinson\u2019s disease","volume":"150","author":"Zhang","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.arr.2024.102538_bib547","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/pro.630","article-title":"Structures of segments of \u03b1-synuclein fused to maltose-binding protein suggest intermediate states during amyloid formation","volume":"20","author":"Zhao","year":"2011","journal-title":"Protein Sci."},{"key":"10.1016\/j.arr.2024.102538_bib548","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3389\/fbioe.2020.00112","article-title":"Antioxidant nanoparticles for concerted inhibition of \u03b1-synuclein fibrillization, and attenuation of microglial intracellular aggregation and activation","volume":"8","author":"Zhao","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.arr.2024.102538_bib549","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.omtn.2018.02.011","article-title":"Novel DNA aptamers for Parkinson\u2019s disease treatment inhibit \u03b1-synuclein aggregation and facilitate its degradation","volume":"11","author":"Zheng","year":"2018","journal-title":"Mol. Ther. -Nucleic Acids"},{"key":"10.1016\/j.arr.2024.102538_bib550","doi-asserted-by":"crossref","first-page":"10128","DOI":"10.1074\/jbc.M307563200","article-title":"Tyrosine-to-cysteine modification of human \u03b1-synuclein enhances protein aggregation and cellular toxicity","volume":"279","author":"Zhou","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102538_bib551","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-018-1194-5","article-title":"Dual modulation on glial cells by tetrahydroxystilbene glucoside protects against dopamine neuronal loss","volume":"15","author":"Zhou","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.arr.2024.102538_bib552","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.bbagen.2012.12.027","article-title":"Oxidized quercetin inhibits \u03b1-synuclein fibrillization","volume":"1830","author":"Zhu","year":"2013","journal-title":"Biochim. Et. Biophys. Acta (BBA)-Gen. Subj."},{"key":"10.1016\/j.arr.2024.102538_bib553","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.bbagen.2012.12.027","article-title":"Oxidized quercetin inhibits \u03b1-synuclein fibrillization","volume":"1830","author":"Zhu","year":"2013","journal-title":"Biochim. Et. Biophys. Acta -Gen. Subj."},{"key":"10.1016\/j.arr.2024.102538_bib554","doi-asserted-by":"crossref","first-page":"26846","DOI":"10.1074\/jbc.M403129200","article-title":"The flavonoid baicalein inhibits fibrillation of \u03b1-synuclein and disaggregates existing fibrils","volume":"279","author":"Zhu","year":"2004","journal-title":"J. Biol. Chem."}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163724003568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163724003568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T03:05:20Z","timestamp":1730516720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163724003568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":554,"alternative-id":["S1568163724003568"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2024.102538","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small molecule modulators of alpha-synuclein aggregation and toxicity: Pioneering an emerging arsenal against Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2024.102538","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102538"}}